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Clinical nephrology
The 1gM nephropathy and minimal change nephrotic syndrome in
adults: A clinicopathological study. X. W. Li, Q. Y. Hang, Z. Q. Bi, et al,
Division of Nephrology, Department of Medicine, Peking Union Med-
ical College Hospital, Bejing, China. Eleven adult 1gM nephropathy
(IgMN) and 14 minimal change nephrotic syndrome (MCNS) cases
were reported in P.U.M.C. Hospital. The clinical and laboratory
manifestations between IgMN and MCNS were quite similar except
that there were more cases with high serum 1gM levels in IgMN than in
MCNS (8/11 and 3/14, respectively; P < 0.001). Although there was no
difference in the response to the first 8 weeks of steroid therapy
(prednisone 0.8—1 mg/kg/d) between the two groups, there were more
recurrences (1 time/I year/case vs. 1 time/2.5 year/case) in the patients
with IgMN. Mesangial proliferative changes, segmental sclerosis, and
global sclerosis were observed in Il/li, 3/11, and 2/li in IgMN, but
none in MCNS. The mesangial electron deposits, GBM thickening and
electron deposits in the GBM were found in 5/7, 7/7, and 1/7, respec-
tively, in IgMN. We conclude from this study that IgMN is a distinct
entity disease and mesangial proliferation is the typical pathological
change in IgMN, but the GBM damage is also present. We do not agree
that IgMN can progress to FSGS, though there are some of our IgMN
patients have been diagnosed with segmental or global sclerosis.
Early stage idiopathic membranous nephropathy. L. Geng, H. 1'.
Wang, and W.Z. Zuo, Division of Nephrology, First Teaching Hospi-
tal, Being Medical University, Being, China. The therapeutic re-
sponse and prognosis of membranous nephropathy has been an impor-
tant topic for clinical nephrology. This study analyzed the clinical and
pathological characteristics of 34 cases of early stage idiopathic niem-
branous nephropathy (MNI). The diagnosis of MNI is dependent on
immunopathology and electron microscopy (EM); it is impossible to
identify this disease by routine light microscopy (LM). Of 34 cases of
MNI, 8 (8/34, 22%) had been misdiagnosed because of thick sections of
LM and lack of immunopathology microscopy or EM data. There was
no difference between MNI, MNII (37 cases) and MNIII (18 cases) in
sex, onset age and manifestation of nephrotic syndrome. But the
patients with MNI had lower incidence of microscopic hematuria,
hypertension and renal function insufficiency (P < 0.01). By short-term
follow-up (9—67 months), the incidence of clinical remission in MNI
patients treated with corticosteroids and cytotoxic agents was 67%,
which was much higher than that in the whole MN group (28%) and the
group of untreated MNI patients (1/7 cases, 14%). This study demon-
strated that patients with early stage MN have a good response to
therapy and a good prognosis. So it is strongly suggested that like many
other glomerular diseases, MN is not a whole disease. MNI should be
treated as a special disease entity.
Possible antigen and its immune deposits: Formation and localization in
human membranous nephropathy (MN) studied by hnmuno-electronic
microscopy. L. Geng and H. Y. Wang, Division of Nephrology, First
Hospital, BeUing Medical University, Beijing, China. To understand
further the procedure of subepithelial deposits and its possible antigen
component of MN, the method of immunoelectronic microscopy (im-
muno-gold technique) was used. The method of single or double marks
was performed on thin sections of low-temperature embedded renal
biopsy tissue of MN with Lowicryl K4M. Our study revealed that, in
early stage MN and stage II, IgG was located not only in dense deposits
of subepithelium, but also in the surface of eplithlium, and also
accumulated in endosome and lysosome. GP16O is present in the
surface of glomerular epithelium and in the brush of proximal tubuli in
normal human beings. Immuno-EM showed 0P160 located in the
deposits and cytoplasm of epithelium in MN with IgG. Immuno-EM
observation also revealed that C5b-9 was located in subepithelial
deposits and cytoplasm of epithelium with IgG or alone. These results
suggest: (1) In human MN, glomerular epithelium, as the main attacked
target, may also play an active role in the endocytosing, transporting
and cleaning of IgG; (2) GP16O acting in the same way as GP330 in
Heymann nephritis, may play an antigenic role in human MN.
Evaluation of the clinical classification in IgA nephropathy (IgAN).
Y.S. Yu and L.S. Li, Jinling Hospital, Nanjing, China. Based on the
clinical criteria, 463 cases of primary IgAN were divided into 7 groups:
Recurrent gross hematuria (31.1%), isolated macroscopic hematuria
(7.8%), urinalysis abnormality (34.8%), nephrotic syndrome (9.3%),
non-nephrotic massive proteinuria (5.8%), hypertension (6.9%) and
acute glomerulonephritis (4.3%). The correlation of clinical manifesta-
tions, renal histology, immunopathology, response to the treatment and
prognosis of the patients in each category were studied. It was found
that they were different clinical entities. The unique features of patients
in each group was delineated. This new clinical classification was
considered to be helpful for the clinical management of IgAN.
Close association of cytomegalovirus DNA (CMV-DNA) with IgA
nephropathy (IgA-N) presenting gross hematuria. Z.H. Liu and L.S. Li,
Jinling Hospital, Nanjing, China. CMV has been suspected to be
involved in the pathogenesis of IgA-N. IgA-N both with and without
recurrent gross hematuria (OH), 10 in each group and cases of mesan-
gial proliferative GN, membranous GN were included in this study.
Sera were obtained and analyzed for the presence of CMV-DNA with
the polymerase chain reaction. A 106 bp DNA fragment of the imme-
diate early gene of HCMV was amplified with specific primers and
analyzed in Southern blot hybridization with 2P-labeled probe. Renal
biopsies of the 20 cases of IgA-N were also analyzed for the presence of
CMV-DNA with in situ hybridization. The results are summarized as
follows:
CMV-DNA(+)
No. Serum Biopsy
IgA-N (OH) 10 7 1
IgA-N (non-OH)
Mesangial proliferative GN
10
10
2
1b
1
Membranous GN 10 2
a <0.05
b P < 0.01
The high frequency of CMV-DNA present in the sera but not in the
renal tissue of IgA.N (OH) implicated that there was a close relation-
ship, but it was not etiologically related. Episodes of OH in IgA-N were
frequently precipitated by upper respiratory infection, notably CMV.
Eradication of the focus of infection (tonsillectomy) is conceivably a
valuable means to lessen the hematuria attacks as we have recently
proved.
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The patterns of serum IgA from patients with IgA nephropathy (IgAN).
J.Q. Qian, J.M. Yun, and J.H. Yao, Renji Hospital, Second Medical
University, Shanghai, China. It has been observed that in patients with
IgAN, polymeric IgA(pIgA) is critical for the renal deposition of
complexes and induction of nephritic histologic changes. To character-
ize the significance of serum pIgA in the patients with IgAN, the serum
levels of total IgA and pIgA were determined in a group of 25 idiopathic
IgAN patients and 40 normal persons (control). pIgA with SC-IgA and
without secretory component (pIgA-SC-IgA) was separated using anti-
Sc. The results (mean SD) are shown below:
IgA(N=
N N
25)
ormal control
(N=200)
Total IgA mg/dl 382.9 123.9a 194.1 68
Normal serum IgA(N = 8.32%) High serum IgA(N = 17.68%) (N = 40)
pigA
SC-IgA
pIgA-SC-IgA
9.23 6.23'
0.57 0.36a
8.66 6.45a
14.07 8.20a
0.49 0.19a
12.93 8.90"
1.11 0.16
0.21 0.10
0.88 0.24
a P < 0.001 as compared with normal control
High serum IgA was found in the patients with IgAN (17.68%). The
levels of pIgA, SC-IgA and pIgA-SC-IgA were significantly high in
IgAN patients (both normal and high serum IgA), especially pIgA
without SC (pIgA). In summary, our data suggest that pIgA may
contribute to the pathogenesis and differential diagnosis of this disease.
The characteristic distribution of extracellular matrix in the glomeruli
of patients with IgA nephropathy. 1.Q. Bai, X.M. Chen, and S.Z. Shi,
Department of Nephrology, Great Wall Hospital, Be(jing, China. The
correlation between the changes of the intensity and distribution of
extracellular matrix and progress of glomerular sclerosis was studied by
indirect immunolluorescence. It was shown in the study of the distri-
bution of type I, III, IV collagens, fibronectin, lamminin in the
glomeruli of advanced stages of IgA nephropathy that the intensity and
distribution of type I, III collagen were marked in the glomerular
mesangium, which extended along the capillary walls and basement
membrane of the glomeruli. The stainings of the type IV collagen,
laminin and fibronectin in the glomerular sclerotic lesion were obvi-
ously increased in IgA nephropathy. It is concluded that hyperproduc-
tion of extracellular matrix may play an important role in the patholog-
ical mechanism of IgA nephropathy.
Lymphocyte function in tonsils in IgA nephropathy (IgAN). Y.S. Yu
and L.S. Li, Jinling Hospital, Nanjing, China. To investigate the
association of tonsillitis with IgAN, tonsillar IL-2, interferron r(IFN-r),
immunoglobulins and lymphocyte subsets were examined in 28 IgAN
patients with gross hematuria and 28 patients with chronic tonsillitis
without IgAN. The IL-2 activity in both tonsils and peripheral blood
was higher in IgAN cases than the non-IgAN controls (P < 0.01), while
the level of IFN-r was not different. The mean content of tonsillar levels
of IgG, 1gM, and IgE were similar between the two groups. The number
of CD4+ lymphocytes in tonsils was higher in IgAN cases. There was
no difference in CD8+ cells or CD4/CDS ratio. It is suggested that there
might be an immuno-regulation abnormality in respiratory mucosal
membranes in IgAN patients. Upper respiratory infections, especially
tonsillitis, may be a trigger to stimulate mucosal immune response
which results in the increase of polymoric IgA (pIgA) production, and
deposition of pIgA immune complex. Tonsillectomy is recommended
for the patients to reduce the episodes of gross hematuria.
HLA-DR gene frequencies in Chinese IgA nephropathy patients deter-
mined by oligonucleotide genotyping. X.M. Chen, L.Q. Bai, Q.L. Cheng,
et a!, Department of Nephrology, Great Wall Hospital, Being, China.
HLA-DR alleles in 255 random health northern Chinese donors and 30
patients with IgA nephropathy (IgA-N) were determined by using a set
of 30 different sequence specific oligonucleotide (SSO) probes directed
to various DRB alleles. These SSOs enabled us to identify 33 different
DRB alleles. Gene frequencies were calculated for each of the DRB
alleles identified by the SSO typing. The results showed that the high
gene frequencies for the alleles DR2, DR7 and DR9 were determined in
the northern Chinese Han's donors, while a significantly high gene
frequency for DRw12 was obtained in Chinese IgA-N patients, espe-
cially in those with massive proteinuria and recurrent gross hematuria.
These results indicated that these people who expressed a high gene
frequency for DRw12 may be the high risk population susceptible to
IgA nephropathy in the Chinese.
Clinico-pathological analysis of 36 cases with focal segmental glomeru-
loscierosis. Q.Y. Huang, X. W. Li, Z.Q. Bi, et al, Division of Nephrol-
ogy, Department of Medicine, Peking Union Medical College Hospital,
Bejing, China. Thirty-six cases of focal segmental glomerulosclerosis
(FSGS) were confirmed in a total of 706 biopsied cases (5.1%) from
1981—1990 in PUMC Hospital. There were 21 males and 15 females;
M:F = 1.4:1, aged 16—64 years (mean 35.3). Under light microscopic
(LM) observation, focal segmental glomerulosclerosis was found in 36
cases (100%), global sclerosis in 36 (100%) and adhesion of capillary
tufts to Bowman's capsule in 36 (100%). The number of cases with
tubular atrophy, focal interstitial fibrosis and arteriolar sclerosis were
25 (60%), 18 (50%), and 6(17%), respectively. The immunofluorescence
examination was performed in 25 cases which showed 1gM in 18 (72%),
C3 in 14 (56%), IgG in 10 (40%), fibrinogen in 5 (20%) and IgA 11(44%)
in segmental glomeruli; 6 cases were negative. Twenty-five cases with
nephrotic syndrome (NS) were treated with prednisone 1 mg/kg/d
associated with cyclophosphomide (CTX) 200 mg i.v. 3 times a week,
total dosage 8—12 grams. Two of them received pulse methylpredniso-
lone intravenous injection 1 gram per day for 3 days. All the 25 cases
were followed up for more than one year. At the end of this therapy
complete remission of NS was seen in 4 (16%), partial remission in 4
(16%), and no change or worse in 17 (62%). We can conclude that all the
36 cases were associated with glomerulosclerosis by LM examination.
In contrast with other reports, IgA deposits were found in our series.
Treatment with steroids associated with CTX was not effective in most
cases.
A clinico-pathological study of crescentic glomerulonephritis. Z. Tang
and L.S. Li, Jinling Hospital, Nanjing, China. Twenty patients with
crescentic glomerulonephritis (CGN) were reported, which accounted
for 0.7% in 2,800 renal biopsies. There was a female preponderance,
with a mean age of 27.5 (11—44) years. All the patients had had a various
degree of abnormal renal function with the 5Cr levels of 142.6—1584.9
rmol/liter. 50% of them had gross hematuria, auria or oliguria. Ne-
phrotic syndrome and hypertension were present in 75% of patients and
anemia in 95%. Except for the crescent formation, the glomerular
sclerosis and severe interstitial lesions were commonly observed in the
renal biopsy. In 16 patients who were followed up for 6—94 months,
end-stage renal failure occurred in 50%, and 4 of them died of renal
failure with severe infection. The severity of interstitial lesions and
infiltration of mononuclear cells in the interstitium were closely related
to outcome. The results demonstrated that immune-complex mediated
CGN (Type II) was absolutely prevalent in the Chinese (85%), com-
pared with the figure (40%) in America; both were anti-GBM antibody
mediated (10%) and immune deposits CGN (5%) were rare. There was
a high incidence of secondary glomerular disease, such as lupus
nephntis and purpura nephropathy. IgAN was an important primary
glomerulonephritis in Type II CGN.
The effect of treatment on the prognosis of type IV lupus nephritis.
X. W. Li, Q. Y. Huang, Z. Q. Bi, et al, Division of Nephrology, Depart-
ment of Medicine, Peking Union Medical College Hospital, Beijing,
China. Twenty-one cases of diffused proliferative lupus nephritis in
P.U.M.C. Hospital were treated and followed up. They were divided
into two groups according to the result of treatment. Group A:
Deterioration group (10 cases), 2 males, 8 females, aged 20 to 48 (mean
31.5) years. At the end of follow-up, 7 patients died of end-stage renal
failure, 2 were alive on hemodialysis and one received non-dialysis
treatment. Group B: Stable or improved group (11 cases), 4 males, 7
females, aged 16 to 58 (mean 30.2) years. The renal function was normal
in all the 11 cases, no proteinuria in 3, nephrotic syndrome was relieved
in 5 but with + to + + proteinuria, 3 still with nephrotic syndrome but
the clinical symptoms were significantly improved. The differences
between clinical data at biopsy between the two groups were as follows:
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Hypertension, Group A, 1/10; Group B, 1/11 (NS); the duration of
follow-up, 62.8 months vs. 34.4 months (P> 0.05); the mean dosage of
prednisone, 19.86 mg/d vs. 25.83 mg/d (NS); the days of therapy total
course, 0.3850 0.085 vs. 0.7891 0.0532 (P < 0.001); the mean doses
of prednisone during the total course, 7.00 1.64mg/d vs. 19.96 1.72
mg/d (P < 0,001); the mean CTX dosage 2.70 0.71 vs. 2.94 0.73
mg/d (F> 0.05); the methylprednisolone pulse therapy (d/patient), 2.10
1.19 vs. 2.64 0.72 (NS); the CTX pulse therapy, 0.30 0.21 vs.
3.45 1.4 (P < 0.05). In conclusion the combined use of prednisone
(0.8—1.5 mg/kgld) and CTX (0.2 g gqd i.v.) with or without methyipred-
nisolone pulse therapy is useful in active lupus nephritis, but no
significant influence to long-term progression. The ratio of therapy
days/course and the mean prednisone dosage in the total course as well
as large dosage CTX pulse therapy were related to the long term
progression. The prednisone treatment for type IV lupus nephritis at the
silent phase is needed at least in the first five years.
Histological transformation of lupus nephritis (LN). H.P. Chen and
L.S. Li, Jinling Hospital, Nanjing, China. Repeated renal biopsy was
performed and analyzed pathologically, immunopathologically and clin-
ically on 38 patients with LN in order to explore the features and
characters of the histological transformation of LN. The results showed
that the histological transformation rate was 44.7% in LN with the
highest transformation rate of class II LN (66.7%), and was 26.7% in
class IV and 33.3% in class V LN, respectively. In general, the
transformation could occur in any type of LN, which was hardly
predicted from the clinical or laboratory findings. However, the activity
of renal lesions, infiltration and distribution of CD4+/CD8+ lympho-
cytes in the interstitium were valuable in evaluating the histological
transformation of LN. More attention should be paid to the cell-
mediated immunity in the pathogenesis of LN.
Tubular interstitial lesions in lupus nephritis (LN). Z. Tang and L.S.
Li, Jinling Hospital, Nanjing, China. Tubular interstitial damages,
clinical manifestations and laboratory findings were observed in 49
patients with LN who had normal glomerular filtration rate. The
prevalence of tubular interstitial damages was 44.9% and 61.2%,
revealed by the urinary acidification function test and renal biopsy,
respectively. Clinical findings were rare and proximal tubular lesions
were minor. The patients with the dysfunction of urinary acidification
were usually associated with anemia and hypo-osmolar urine, and had
marked lesions and serological and immunological abnormalities.
Observation of improved cuyoxin pulse therapy for lupus nephritis.
R.G. Ye, X.P. Li, H.Q. Li, et al, Renal Research Institute of Sun
Yat-Sen University of Medical Sciences, Guangzhou, China. Twenty-
five cases of active lupus nephritis (LN) were given improved CTX
pulse therapy (therapy group) and another 25 similar cases received
conventional high dose prednisone therapy (control group) as control.
CTX pulse therapy is recommended as follows: Initial dose of CTX
8—12 mg/kg, put into NS 100 ml, is prepared for i.v. drip, once a day for
two days and repeated after two weeks, total dose 150 mg/kg. For
maintenance, same two-day CTX infusion is given every three months.
WBC counting is taken once a week in treating time and once a month
in maintenance period. If WBC counting is taken once a week in
treating time, once a month in maintenance period, and if WBC is less
than 3000/mm3, CTX therapy should be suspended, Conventional
prednisone is used together with the initial CTX administration. We
observed patients for two years. Average remission time of therapy
group was 40.3 22.3 days but 69.0 36 days in the control group (P
< 0.01). No dead case was seen in therapy group but 2 were in the
control group (P < 0.01). All cases in the therapy group achieved
satisfying remission and only one recurred. Three cases in the control
group failed to achieve the remission and 8 recurred (P < 0.01). This
result showed a better therapeutic effect and rare side-effect of the CTX
pulse therapy. The authors suggest that this improved CTX pulse
therapy should be used for the active LN patients, especially for the
following cases: (1) cannot be tolerant of high dose prednisone; (2) in
the course of prednisone reduction, recurring is present; (3) obvious
side-effects appear in the long-term administration of prednisone.
Renal involvement of primary vasculitis: Clinical and pathological
analysis of five cases. M.H. Zhao, H. Y. Wang, and Y.K. Zhang,
Nephrology Department, The First Hospital, Being Medical Univer-
sity, Beijing, China. Primary vasculitis, including microscopic poly-
arteritis (MPA) and Wegener's granulomatosis (WG), is one of the
causes of glomerulonephritis and renal failure. Recently, antineutrophil
cytoplasmic autoantibodies (ANCA) have been used as an important
tool for the diagnosis of MPA and WG. Assay of ANCA was performed
in 42 patients with crescent formations or sclerotic glomerulonephritis,
Five of them showed positive ANCA, all in the pattern of P-ANCA.
Most of the patients were elderly male, with fever, malaise, weight loss,
anemia, muscle and joint pain. Some of them had chronic cough, even
hemoptysis, and opacities in middle-lower fields of both lungs, which
didn't respond to antibiotics. Our results suggest that renal failure
caused by primary vasculitis is not rare in China.
Circulating autoantibodies to neutrophil cytoplasmic antigens (ANCA)
in patients with Henoch.Schonlein purpura (HSP) and IgA nephropathy(IgA-N). Z.H. Liu and L.S. Li, Jinling Hospital, Nanjing, China.
ANCA, originally discovered in patients with Wegener's granulomato-
sis, has recently been detected in a few patients with HSP, systemic
vasculitis and nephritis. IgA-N is not a homogenous disease clinico-
pathologically. It has been suggested that HSP might share a common
pathogenesis with some cases of IgA-N. Sera from patients with HSP
nephritis (HSP-N), primary IgA-N presenting gross hematuria (GH),
and primary IgA-N not showing gross hematuria (N-GH), were exam-
ined for ANCA (IgA, IgG, and 1gM) with indirect immunofluorescence.
The results were summarized as:
ANCA
n
positive
(%)
IF type
IgA IgG 1gM
HSP-N 18 8 (44.4) 5 6 2
IgA-N (GH) 18 4 (22.2) 2 3 0
IgA-N (NGH) 20 1 (4.6) 1 1 0
Autoantibodies to ds-DNA, ANF and rheumatoid factors in serum were
all negative. Serum TNF levels in patients with ANCA were not
different from those with negative results. Patients with IgA-N (GH)
were younger than those with IgA-N (N-GH), rather similar to the
HSP-N group. Renal biopsy in the IgA-N (GH) group showed more
features of vasculitis resembling that in the HSP-N group. It was
presumed that some of the so-called "primary IgA-N" presenting gross
hematuria and positive ANCA might be HSP-N, though pathogeneti-
cally devoid of skin lesions.
Thin membrane nephropathy (TMN): An analysis of eight cases. Y.K.
Zhang, H. 1'. Wang, L. Geng, et al, Being Medical University, Beijing,
China. This study reported 8 cases of TMN for the first time in China.
Seven of the 8 patients had persistent microscopic hematuria, also
accompanied by mild proteinuria or macroscopic hematuria. Contrast
microscopy examination showed glomerular hematuria in most of the
cases. Two of the 8 cases had familial histories of hematuria, suggesting
a possible heredity tendency. All patients had normal renal function at
the follow-up period (averages 2.9 years). LM showed mild pathological
lesions; IF was negative, and diffuse thin GBM was the predominent
change under EM. The thickness of GMN was 270 39 nm in these
patients, 383 32 nm and 398 39 nm in the IgAGN (6 cases) and the
normal control (5 cases). The GBM in TMN was significantly thinner
than that in the IgAGN and the normal control (P < 0.01). This work
emphasizes the importance of EM examination in renal pathology.
Study on pathogenesis of HBV in renal disease by dot blot hybridization
and immunohistochemistry method. f.M. Feng, et al, The First Affili-
ated Hospital, China Medical University, Shenyang, China. In this
experiment, 139 renal biopsy specimens were studied for HBAg pre-
cipitation using biotin avidin system (BAS) method. Among them,
HBsAg and HBcAg precipitation accounted for 27% (38/139) and 23%
(9/40), respectively. Fifty-five specimens were studied for HBV-DNA
with a-32p labeled cloned HBV genome probe (HBV-PBR 322), and 12
of them were positive (21.8%). In this HBV-DNA positive group, both
membranous and mesangial proliferation types were 45% and 25%,
respectively. Using BSA method, 57% of the HBsAg positive cases
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showed the same precipitation sites for HBAg, 1g. C3 and FRA, and the
sites were corresponding to that of pathological lesion. There was no
relationship between HBV-DNA positive in renal tissue and HBAg
positive in blood. Electronic microscopy showed that in some cases,
electron dense was deposited in multiple sites (mesangial area, suben-
dothelial, subepithelial or intra-GBM). The results suggested that HBV
should be replicated within kidney and the pathogenic effects be
mediated by immunocomplexes. Whether or not the complete viruses
may directly damage the kidney remains to be studied further.
Gene testing in autosomal dominant polycystic kidney disease:
(ADPKD)-linkage analysis between ADPKD gene and 24-1 probe. S.L.
Zhu, Y.C. Liu, M.S. Qi, et a!, Division of Nephrology, First Teaching
Hospital, Beijing Medical University, Beijing, China. ADPKD is one of
the most common hereditary diseases in the Chinese population.
Recently, S.T. Reeders and colleagues localized the genetic locus
whose mutation causes ADPKD chromosome l6pl3 to be tightly linked
to the a-globin gene cluster. In an attempt to know if the gene mutation
also occurs in Chinese ADPKD patients, we used the 24-1 as a probe
(offered by Dr. Klaus Zerres from Bonn University) in genetic RFLP
studies on genomic DNA Taq I fragments of blood samples from five
Chinese families, of which five members were affected by ADPKD, two
unaffected, and two unrelated normal Chinese. The preliminary results
showed that the hybrids between 24-I probe can be used for presymp-
tomatic and prenatal diagnosis of ADPKD in the Chinese.
The analysis of 19 glomerulonephritis patients complicated with hemop-
tysis. Y.K. Zhang, J.H. Pang, and H. Y. Wang, Division of Nephrology,
First Hospital, Beijing Medical University, Beijing, China. Cases of
hemoptysis in 19 glomerulonephritis patients were analyzed. Two of
them (2/19 cases, 11%) were due to Goodpasture syndrome, others
were RPGN (type II) with hemorrhagic interstitial pneumonia, ne-
phrotic syndrome (NS) complicated with pulmonary artery thromboem-
bolism, SLE with pulmonary interstitial disease or vessel disease, and
microvasculitis with pulmonary small vessel lesions. Chronic glomeru-
lonephritis complicated with heart failure and glomerulonephritis ac-
companied with bronchiastasis could also be contributed to hemopty-
sis. The therapeutic results showed that the hemoptysis could be
stopped; clinical symptoms could be improved rapidly in the patients
with microvasculitis, NS with pulmonary artery thromboembolism, and
most of the SLE patients. This suggests that for the glomerulonephritis
patients complicated with hemoptysis, the diagnosis should not only be
on the classical Goodpasture's syndrome, but also on the consideration
of other causes.
The study on librinolytic activity in renal artery, renal vein and cubital
vein of patients with primary nephrotic syndrome. X.F. Sun, L.C. Wang,
et al, The First Affiliated Hospital of China Medical University,
Shenyang, China. Renal veinography was performed in 6 cases of
primary nephrotic syndrome (NS), 3 of them complicated with renal
vein thrombosis (RVT). a2-plasmin inhibitor-plasmin complex (a2-PIC)
and plasminogen (PLG) were measured by ELISA. (1) The a2-PIC level
in the cubital vein of NS patients was significantly higher (P < 0.01),
and the PLG level was significantly lower (P < 0.05) than that in healthy
persons. The a2-PIC level of the renal vein was significantly higher than
that in the cubital vein (P < 0.05). The PLG level in the renal vein was
significantly lower than that in the renal artery (P < 0.05). These
findings suggest that local fibrinolytic activation was increased in NS
patients. It might be related mainly to the consumption by local
fibrinolytic activation and urine leakage. (2) In NS patients complicated
with RVT, the a2-PIC level in the renal vein was higher than that in the
renal artery (P < 0.05). This suggests that the formation of RVT
indicates the increase of local fibrinolytic activity. Seral a2-PIC increase
of NS patients is also caused by the fibrinolysis after RVT formation.
The study of fibrinolytic activity in primary nephrotic syndrome and
urokinase therapy. L.C. Wang, et al, The First Affiliated Hospital,
China Medical University, Shenyang, China. In this study the fibrin-
olytic activity of pre- and posturokinase (UK) therapy was observed in
16 cases of primary nephrotic syndrome. UK treatment lasted 2—4
weeks at the dose of 120,000—300,000 U/d. There were 5 cases in the
thrombotic group (4 with thrombus of the renal vein and with embolism
of the iliac artery), 11 cases in the nonthrombotic group and 20 subjects
in the normal control group. The results were as follows: I. Before
treatment: (1) Compared with the control group, a2-plasmin inhibitor-
plasmin complex (a2-PIC) (ELISA) in the nonthrombotic group signif-
icantly increased (P < 0.01). However, a2-plasmin inhibitor (a2-PI),
plaminogen (PLg) and a-antitrypsin significantly decreased (P < 0.05,
P < 0.001, P < 0.001). This result suggested that the fibrinolytic system
was activated. (2) a2-PI in the thrombotic group was significantly higher
than that of the nonthrombotic group (P < 0.05), and showed the
highest value in 4 cases of thrombotic group when measured individu-
ally, suggesting an increase in plasmin inhibitor accompanied by
activation of fibrinolytic process in the group of thrombus. The increase
of both a2-PI and a2-PIC might serve as a parameter to monitor the
thrombosis in NS. II. After treatment: a2-PIC increased significantly
after UK treatment (P < 0.05) and showed a certain relationship
between dose and effect. The significant decline of a2-PI PLg and
fibrinogen (P < 0.01, P < 0.05, P < 0.05) indicated that UK 120,000—
300,000 U/d can activate the fibrinolytic system effectively. Therefore,
a2-PIC and a2-PI can be employed to monitor the effectiveness of
fibrinolytic therapy.
Receptor response to glucocorticoid in nephrotic syndrome. L.P. Yang,
G.Z. Xu, and SM. Huang, Department of Nephrology, First Hospital,
West China University of Medical Sciences, Chengdu, China. Gluco-
corticoid receptor (GC-R) measured as the specific binding of (3H)-
dexamethasone with a whole cell assay in peripheral WBC in 29
patients with nephrotic syndrome (NS) (X = 2118.7 1630 sites/cell)
did not appear to correlate with the control group (C.G.) (X = 2140
1548 sites/cell; N = 20); P > 0.25). All patients were treated with
prednisone 1 mg/kg d 12 w, and divided into the following groups:
Complete remission group (C.R.) N = 13, X = 2958 sites/cell; part
remission group (P.R.) N 7, X = 2296.4 sites/cell; no effect group(N.G.) N = 9, X = 768.1 sites/cell. There was a notable difference
between N.G. and C.G. (P < 0.01). The GC-R level of C.R. and P.R.
was higher than that of N.G. (P < 0.01, P < 0.001). The response to
glucocorticoid therapy appeared to correlate with the GC-R level of
WBC (P < 0.05). The patients showed a progressive decrease in
receptor number during glucocorticoid administration. Twelve of the 29
patients were subjected to renal biopsy: MsPGN (8), MPGN (3), and
FSGS (I). There was no relationship between pathologic type and GC-R
level (r = 0.079, P > 0.5). The data suggest that NS patients' GC-R
level can be used as a practical predicator in patients with clinical
sensitivity to glucocorticoid therapy.
Alteration of glomerular anionic sites in human glomerulonephritis.
Z.Q. Wang, X.J, Zhou, and Q. Ren, Department of Nephrology, First
Affiliated Hospital, China Medical University, Shenyang, China. The
relation of ultrastructural alterations of glomerular anionic sites to
morphological changes of the glomerular basement membrane (GBM)
was studied by electron microscopy using polyethyleneimine (PET) as a
cationic probe. Biopsy specimens were obtained from the following
patients with several glomerulonephrotides: 4 mesangial proliferative
glomerulonephritis (M5PGN), 2 membranous nephropathy (MGN), and
3 membranoproliferative glomerulonephritis (MPGN). Control speci-
mens were obtained from intact parts of the kidney from 2 patients with
kidney tumors. Small tissue blocks were immersed in 1% PEI (m.w.
10,000, pH 7.3) solution to demonstrate the anionic sites. In control
specimens PET stained particles were localized in the lamina rara
externa (LRE) and epithelial cell surface with regular distribution. In
patients with MGN (Stage II and III) and MPGN (Type III), the anionic
sites on GBM disappeared completely in the area covering many
deposits or disappeared partially in the area covering fewer deposits. In
patients with MPGN (Type III), we have also seen the newly formed
GBM-like materials with PET particles on both sides. In patients with
MsPGN, the alteration of anionic sites on GBM in number and size was
much less, almost unaltered. These findings suggest that the alteration
of anionic sites on GBM was associated with the deposition of immune
complex.
Is the renal dopamine involved in the sodium retention in the nephrotic
syndrome? F.F. Hou and X. Zhang, Department of Nephrology,
Nanfang Hospital, Guangzhou, China. Previous studies have shown
that the sodium retention in nephrotic syndrome (NS) may be due
primarily to an intrinsic inability of the nephrotic kidney to excrete salt
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and water normally, but the mechanism for this is unclear. Recently, it
has become apparent that renal dopamine (DA) is an important intra-
renal natriuretic hormone, We carried out a study to determine whether
the urine DA response to sodium loading was normal in patients with
NS, Twenty patients with normal CCr and 10 age-matched normal
volunteers were given additional sodium chloride under conditions of
metabolic balance, When they were on a low salt diet (34 mmol/d),
urinary excretion of DA and sodium in patients with heavy edema was
much lower than that in the normal controls, while in patients with mild
or without edema, urinary DA and sodium excretion did not decrease
significantly, but was not mobilized on high sodium loading (170
mmolld), and the plasma renin activity and aldosterone were not
completely suppressed as well. The decrement of urine DA excretion
was independent of Cr or the severity of renal tubule lesions, but was
associated with the severity of proteinuria. When the proteinuria was
reduced, urine DA and sodium excretion increased rapidly. From the
above observations, we might assume that the abnormal retention of
sodium and water in NS was due partly to a failure to mobilize DA in
the kidney, and the change of the physical environment in renal tubule
caused by heavy proteinuria may be responsible for it.
Sex hormone level in patients with renal disease and its clinical
significance. X. Y. Ma, G.Z. Xu, T.N. Yu, et a!, Department of Nephrol-
ogy, First University Hospital, West China University of Medical
Sciences, Chengdu, China. The sex hormone level, including prolactin
(PRL), follicle-stimulating hormone (FSH), luteotropic hormone (LH),
testosterone (T), and estradiol (E2) was studied in 108 patients with
renal diseases by radioimmunoassay (RIA). In 108 patients, (60 males
and 48 females, age range 14—80 years) normal renal function (group 1)
was noted in 35, compensative stage of renal insufficiency (group 2)15,
nitrogenemia (group 3) 21, and uremia (group 4) 33. The distribution of
primary diseases was as follows: Glomerulonephritis, 32 patients;
nephrotic syndrome 21, chronic pyelonephritis 6; gout 3; lupus nephritis
5, diabetic nephropathy 3, interstitial nephritis 2, ARF I. Fasting
venous blood samples were obtained at 7:30 to 8:00 am. for basement
levels of PRL, FSH, T, E2 and LH. Eleven of 33 patients were treated
by continuous peritoneal dialysis, and the blood of all patients was
drawn at 24 hours, 72 hours, and I month after the initiation of dialysis
for the progressive changes of these hormones. PRL was significantly
higher in the uremia group (group 4, P < 0.05). The PRL level
correlated positively with serum creatine and BUN. In the uremia
group, LH was elevated, and T was decreased slightly. There was no
statistic significance. No clear correlation was noted between FSH, LH
and BUN. There was no significant decrease in PRL 1—30 days after
dialysis, The T level was decreased in male patients and increased in
female patients before dialysis. T level was restored in some patients
after dialysis. Significant elevation of PRL level during renal insuffi-
ciency may be due to the decrease of renal clearance rate and the
disturbance of PRL secretions of hypothalamus and pituitary gland.
Among 11 dialysis male patients, 6 had restored libido 3—7 days after
dialysis together with the restoration of T level.
Pathologic analysis of glomerular disease in 131 children patients. Z.L.
Zhou, Y.P. Wang, J.G. Wang, et a!, Department of Nephrology, 281
Hospital, PLA, Beidaihe, China. Of 131 cases, 85 were male and 46
female, with a mean age of 9.01 years (2.25—14 years), and a mean
disease course of 16.2 months (5 days—132 months). The cases included
24 acute glomerulonephritis (GN); 5 protracted UN; 4 chronic GN; 38
simple nephrotic syndrome; 21 nephntis nephrotic syndrome; 17
asymptomatic proteinuria and/or hematuria; I postural proteinuria; I
hereditary nephritis; 28 Henoch-Shonlein nephritis, and 2 lupus nephri-
tis. In comparison of the pathologic results and therapeutic effects, it
was shown that of 9 cases of endocapillary proliferative (ENP) GN, all
were cured; of 7 minimal change disease (MCD), all were in complete
remission; of 7 minor lesion (ML), 6 were in complete remission and I
in improvement; of 37 mild mesangial proliferative nephritis (MsPGN),
31 were in complete remission and 6 in improvement; of 9 moderate
MsPGN, 4 were in complete remission, I in basic remission and 4 in
improvement; of 15 IgA nephropathy (IgAN), 7 showed complete
remission, 1 basic remission and 7 improvement; of 8 1gM nephropathy
(IgMN), 2 were in complete remission, 4 in improvement and 2 in no
avail; of 5 membranous nephritis (MN), 2 were in complete remission,
1 in basic remission and 2 in improvement; of 2 focal proliferative (FP)
UN, all showed complete remission; I case of focal glomerulosclerosis
(FUS) and 1 case of membranoproliferative UN (MPGN) showed
improvement; of 28 cases of Henoch-Shonlein nephritis (HSN) as of
MsPUN, 24 showed complete remission, I basic remission and 3
improvement; and of 2 cases of lupus nephritis, 1 of MsPGN showed
complete remission and I of MPGN showed no effect. It was concluded
that in 131 cases of primary, secondary, and hereditary GN, the primary
MSPGN accounted for 69%. The therapeutic effect was closely related
with the pathologic type and the degree of histopathological damage,
and the MN in children appeared to be in relation to hepatitis B virus
infection.
A clinicopathological study on renal biopsy in 75 consecutive cases of
child nephrotic syndrome. X.A. Xie, H.H. Ma, X.Z. Huang, et a!,
Department of Pediatrics, Liuhuaqiao Hospital, Guangzhou, China.
The distribution pattern of pathological types in child nephrotic syn-
drome (CNS) reported in China is quite different from that in other
countries. Consecutive renal biopsies were performed in 75 non-
selective patients of CNS, with a range in age from I to 13 years, in a
period from 1985 to 1990. The pathological results revealed minimal
change disease (MCD) in 21 cases, mesangial proliferative glomerulo-
nephritis (MsPUN) in 26 cases, IgA nephropathy (IgAN) in 9 cases,
membranous nephropathy (MN) in 9 cases, focal segement glomerulo-
nephritis (FSUS) in 5 cases, membranoproliferative glomerulonephritis
(MPGN) in 4 cases, crescentic glomerulonephritis (CrGN) in 5 cases
and diffusive glomerulosclerosis (DUS) in 2 cases. In this study, the
proportion of MCD (28%) is smaller than that in other countries and
even smaller than the proportion in reports of selective renal biopsies.
MsPUN (33%) and MN (12%) are larger than the proportion in other
reports. The large proportion of MN may be due to HBV infection,
because all patients with MN demonstrated positive in serum HBsAg.
All MCD and about 65% of MsPUN showed as simple type NS, all
CrGN and DGS manifested as nephritic type NS, and about half of
IgAN, FSGS and MPGN demonstrated as simple type NS. Thus, MCD
can be obviated if the clinical manifestation is nephritic type NS. Our
clinical data showed that the effect of the corticosteroid on MCD and
MN was better than on other pathological types, and only one case of
MCD was steroid non-responsive. 28% cases of MsPGN demonstrated
steroid response by the end of the eighth week. However, 72% of the
cases had complete remission in follow-up.
A clinicopathologic study of 28 children with asymptomatic hematuria.
J.H. Zhou, Y.Q. Wang, 0. Y. Xu, et al, Section of Nephrology,
Department of Pediatrics, Tong/i Hospital, Tong/i Medical University,
Wuhan, China. Renal biopsies were performed in 28 children with
asymptomatic hematuria, and the clinicopathologic correlation was
studied. The results showed that MsPUN (25%), thin basement mem-
brane disease (TBMD, 17.9%) and minor lesion (35.7%) were the major
pathologic types in the Chinese children with asymptomatic hematuria.
Other pathologic changes were also found, such as Alport's syndrome
and extracapillary proliferative glomerulonephritis (7.2%, respective-
ly), FSGS and intracapillary proliferative glomerulonephritis (3.6%,
respectively). Analysis of the clinicopathologic correlation showed that
TBMD is more common in children with persistent hematuria than in
those with intermittent hematuria, but MsPGN and minor lesions were
similarly distributed in both persistent and intermittent hematuria
groups. Controlled study was carried out in 5 children with TBMD and
5 with minor lesions. The results showed that the mean age of onset of
children with TBMD was much younger than those with minor lesions(3.6 vs. 9.8 years, P < 0.01); the glomerular basement membrane
(GBM) of TBMD was much thinner in the mean thickness than that of
minor lesion (226 vs. 336 nm, P < 0.01). So the thickness of GBM < 250
nm may be regarded as the borderline for diagnosing TBMD, which was
not overlapped in both groups.
The changes and significance of serum tumor necrosis factor in children
with glomerular diseases. X. Y. Jiang, Y. Cai, Y.Z. Chen, and M.C. Hu,
Department of Pediatrics, The Affiliated Children's Hospital, Nanjing
Medical College, Nanjing, China, Tumor necrosis factor (TNF), one of
the cytokines secreted by monocytes and activated by lymphocytes,
plays an important role in the anti-tumor activity and the pathogenesis
of immunity, inflammation, coagulation and shock. In order to observe
the changes of TNF in children with glomerular diseases, the serum
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TNF of 60 children with glomerular diseases was measured with in vitro
cell cytotoxic assay. The data showed that in acute phase, the level of
serum TNF in children with primary nephrotic syndrome (44.34 17.82
U/mI), acute glomerulonephritis (71.38 34.92 U/mI) and purpuric
nephritis (47.33 17.55 U/mI) was significantly higher than that in the
control (10.57 4.35 U/mI, P < 0.001). In the period of remission or
recoveries, the level of serum TNF was markedly decreased (16.00
6.05, 18.29 11.04, and 18.50 8.80 U/mi, respectively), which was
significantly lower than that in acute phase but still higher than that in
the control. In the acute phase, the level of serum TNF in children with
acute glomerulonephritis was the highest of these three types of
diseases, and in remission, there was no significant difference among
them. The results, that serum TNF in children with these glomerular
diseases elevated abnormally, suggested that TNF may play an impor-
tant role in the pathogenesis of the glomerular injury.
Clinical analysis of 42 children patients with dengue fever nephritis
(DFN). J.Z. Huang and Z.G. Lin, People's Hospital of Hainan Prov-
ince, China. Of the 588 children patients with Dengue Fever, 42 (22
male, 20 female) were diagnosed with DFN and were hemorrhagic type.
Among the 42 cases, only one suffered from nephrotic syndrome before
this attack. Most DFN (78.5%) occurred on the 4th—7th day of the
course, while the earliest occurred on the 2nd, and the latest on the 9th.
They all manifested fever (39—40°C), petechial hemorrhage, hepatomeg-
aly, lymphodenectasis, leukocytopenia, thrombocytopenia, edema and
oliguria (proteinuria and hematuria). Five cases were hypertensive, 24
cases complicated with shock syndrome were hypotensive (6.7—0 KPa).
Seven cases of hemorrhagic type developed renal failure. The manage-
ment of DFN included maintaining water electrolyte balance, improv-
ing general microcirculation, increasing renal blood flow. Depression of
temperature, remission of toxinemia and immune suppression oc-
curred, and furosemide and Dextran-40 were given to seven patients
with renal failure.
Nutcracker phenomenon in children with orthostatic proteinuria: 6
cases reported. J. Y. Yang, K.M. Bai, Y.X. Lu, et a!, Pediatric Depart-
ment, First Teaching Hospital, Beijing Medical University, Beijing,
China. Nutcracker phenomenon (NCP) (entrapment of left renal vein)
was found in 6 patients with orthostatic proteinuria by ultrasonography
(US), All 5 boys and a girl were of school age. They showed an isolated
orthostatic proteinuria. The clinical manifestation and the results of US
examination showed as follows:
Case
Sex!
age
yr
Proteinuria
H
NCP
(US)
Enhance-
ment in
UPR LP mg/24 hrs
1 M!7 — ++ 275 — + +
2 M/8 - ++-t- 20 - + +
3 F/8 — + 127—308 — + +
4 M/l4 — ++ 135 — + ND
5 M!12 — ++++ 218 0—1!
HP
+ ND
6 M/9 - ++ 63 - + ND
Abbreviations are: R, recumbent; LP, lordotic posture; UP, upright
position; H, hematuria.
Case 3: Proteinuria was found during a screening test in school in an 8
year-old girl. There was no history of renal disease in the past or in her
family. During 2 years follow-up in the clinic, she was diagnosed as
isolated orthostatic proteinuria. IVP was normal. The entrapment of left
renal vein was found in US. The diameter of LRV between the aorta
and superior mesenteric artery was 2 mm, and at the left side of aorta
it was 9 mm. In an upright position, it widened to 11 mm. NCP may
cause either hematuria or orthostatic proteinuria. Sufficient relief of
LRV entrapment in the supine position was found only in patients with
orthostatic proteinuria, but not in hematuria. Enhancement of the
obstruction of LRV in an upright position was found in our patients.
Considering a high incidence of orthostatic proteinuria in school-age
children, the NCP as one of its causes should be considered and an US
examination might be a convenient way of diagnosis.
State of HBV DNA in renal tissue of child HBV-associated glomerulo-
nephritis. I.J. Fang, et a!, Children's Hospital, Shanghai Medical
University, Shanghai, China. It has been reported that after infection of
HBV in adults, in addition to liver tissue, HBV DNA was detected in
extrahepatic tissues and cells, including pancreas, skin, white cells and
kidneys. However, it was controversial in the results of the state of
HBV DNA in renal tissue of child HBV-associated glomerular nephritis
(GN), though the presence of HBV antigens, such as HBsAg, HBeAg
were observed in these tissues. In this report, the state of HBV DNA in
renal tissues from 5 cases of child HBV associated GN was presented.
DNA was extracted from renal tissues, digested with EcoRI and
hybridized with 32P labeled HBV DNA probe after gel electrophoresis
and southern transfer. In two of five cases, a band of high molecular
weight genomic DNA and free replicating HBV DNA was observed in
DNA without EcoR! digestion. After enzyme digestion, in addition to
the 3.2 kb free HBV DNA, multiple bands between 7—20 kb were
detected, indicating the integration of HBV DNA into cell genome. The
presence of integrated viral DNA excluded the possibility of contami-
nation of HBV DNA derived from serum. In the other 3 cases, a band
of 3.2 kb was detected in both lanes of digested and undigested DNA.
Since no smearing bands (below 3.2 kb) which represented the repli-
cating intermediates have been detected, the 3.2 kb bands should
indicate the presence of non-replicating or mutated free HBV DNA in
renal tissues rather than DNA derived from contaminated Dane parti-
cles of sera. The presence of HBV DNA seems to be closely correlated
with data of HBV antigens detected by immunohistochemical assay. It
is evident that HBV DNA was present in the renal tissues from some
cases of child HBV-associated GN.
A study of the mechanism of edema formation in children with
nephrotic syndrome (NS). 1'. Peng, B.L. Wang, and Y.X. Lu, Depart-
ment of Pediatrics, the First Hospital, Beijing Medical University,
Beijing, China. The pathogenetic mechanism leading to edema forma-
tion in NS still remains unclear. It should be stressed that the measured
plasma volume does not represent effective circulatory plasma volume
(ECPV). It only indicates total plasma volume. It is very difficult to
determine ECPV directly at present. To study the change of ECPV in
NS, we investigated the regulating role of atrial natriuretic peptide
(ANP), its second messenger-cGMP and angiotensin II (A!!) in fluid and
sodium metabolism or NS. Plasma levels of ANP, cGMP and All were
measured by specific radioimmunoassay in edematous and remission
phases, before and after infusion of low molecular dextran in 16 steroid
sensitive nephrotic children, and 14 normal controls as well. Our main
results are as follows: (1) Plasma ANP and cGMP were decreased
significantly, while plasma All was markedly increased in the edema-
tous phase as compared with the remission phase (P < 0.005, <0.05 and
<0.02). Plasma ANP showed a positive correlation with urinary Na
output (UNV) (r = 0.51, P < 0.005, N = 32), and plasma All showed
a negative correlation with UNaV (r = —0.47, P < 0.01, N = 32). A
negative correlation was found between plasma ANP and All (r =
—0.55,P < 0.001, N = 32). (2) After dextran infusion, plasma ANP and
cGMO rose (P < 0.005, each), plasma All and hematocrit (Hct) fell (P
< 0.05, each). Plasma ANP and cGMP showed a negative correlation
with Hct, respectively. As a result, diuresis and natriuresis were
induced. (3) Compared with normal controls, edematous nephrotic
children had lower plasma levels of ANP and cGMP, and higher plasma
level of All (P < 0.05, each), while children in remission had similar
plasma levels of ANP, cGMP and All. These results suggest that
decreased levels of plasma ANP and cGMP, and elevated level of All
are the markers of reduced ECPV in the edematous phase. The increase
in ECPV is the important mechanism which triggers these hormonal
changes. It can be concluded that the reduced ECPV results in sodium
retention and edema formation in steroid-sensitive nephrotic children.
Retlux nephropathy in adults and in experimental pig models. F.X.
Huang, Y.J. Li, P.G. Ye, et al, Kidney Research Institute, Sun Tat-Sen
University of Medical Sciences, Guangzhou, China. Chronic recurrent
non-obstructive urinary tract infection (UTI) was investigated in 56
adult patients. The experimental VUR and RN model was made in
Chinese pigs. Our results were: (1) VUR was found in 30.4% (17/56)
patients (females, 16, male, 1) by MCU. (2) There was no significant
difference between patients with and without VUR in serum creatinine
(5Cr)' The former had a higher incidence of reduction maximum urinary
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concentration than the latter (94% vs. 38.7%, P < 0.05). (3) Twenty-
four (42.9%) of 56 patients were diagnosed as having RN. The patients
with VUR had a higher incidence of RN than those without (64.7% vs.
33.3%, P < 0.05), while the patients with RN had a higher incidence of
VUR than those without (42.2% vs. 18.8%, P < 0.05). (4) The renal
function deteriorated (Se,. > 132.6 mol/liter) in RN patients with
proteinuria more frequently than those without (61.5% vs. 9.1%, P <
0.05). (5) By destroying the unilateral vesicoureteral junction by oper-
ation, the Chinese pig model with VUR and RN was established first in
China. (6) The VUR models with UTI had a higher incidence of FSGS
than those without (100% vs. 28.6%, P < 0.05). More obvious tubular
atrophy, reduction of urinary concentration and increase or excretory
amount of proteinuria occurred in those with UTI than in those without.
These findings suggest that the UTI might play an important role in
renal damage in RN, and the proteinuria might represent a sensitive
index for glomerular lesions and prognosis of RN. (7) In the experimen-
tal VUR models, the results of DRC for detecting VUR were compared
with those of MCU. Agreement between the two methods was 91.8%.
The sensitivities of the two methods were similar. The specificity of
DRC was 92.3%, However, DRC could serve as a highly sensitive and
specific new method for detecting VUR. (8) Because we made the VUR
model without any obstruction and the pressure in the bladder had no
significant difference before and after operation, we consider that no
high pressure, sterile reflux could cause renal damage (RN).
Tubulointerstitial lesions in 820 renal biopsy specimens. C.L. Hao, Q.
Chu, J.Q. Qian, et a!, Department of Nephrology, Rui-Jin Hospital,
Shanghai Second Medical University, Shanghai, China. To evaluate
the degree of tubulointerstitial lesion and its significance in various
types of nephritis, clinicopathological studies were conducted in 669
cases of primary glomerulonephritis, 131 cases of lupus nephritis, and
20 cases of tubulointerstitial nephritis. The degree of tubulointerstitial
lesions was assessed semiquantitatively by light microscopy and was
correlated with histopathological and clinical parameters at biopsy. It
was observed that the most severe grade of tubulointerstitial change in
primary glomerulonephritis, except in crescentic nephritis, was in
FSGS and UgA nephropathy. In the lupus nephritis, the most evident
change of tubulointerstitial lesion was in the type IV. In tubulointersti-
tial nephritis, most severe change was in the chronic tubulointerstitial
nephritis. In the above three types of nephritis, the severity of glomer-
ular injury and the clinical renal insufficiency at the time of biopsy were
positively correlated with the degree of tubulointerstitial change in the
renal cortex area. It was concluded that semiquantitative evaluation of
tubulointerstitial change in the renal cortex could reflect the severity of
glomerular injury and contributed to the assessment of prognosis in
three types of nephritis.
Endotoxemia and interstitial nephropathy. G.Z. Xu, I.P. Yang, X. R.
Liu, et a!, Department of Nephrology, First Hospital, West China
University of Medical Sciences, Chendu, China. Endotoxin, which is
the main parietal component of Gram negative bacteria, is mainly
composed of lipids and polysaccharides. This study explored the
interstitial nephropathy resulting from the endotoxemia. Endotoxin was
injected to 36 female adult Wistar rats intraperitoneally at a dose of 0.5
mg/kg. All rats were killed at 0.5, 1,2,3,6,9, 12,24 hours, respectively
after the injection. LM and EM revealed swelling degeneration of
tubular cells, swollen mitochondria, decreased matrix, and infiltrated
inflammatory cells. Enzymohistiochemistry showed a decrease of oxi-
dation-reduction activity, especially in the MDH-ase and LDH-ase.
Those changes were most prominent twenty-four hours after the
injection, but insignificant in the serum creatinine and BUN. The results
of this study showed that the energy metabolism of tubular cells was
damaged, thus inhibiting the respiratory Chain activity of mitochondria
during endotoxemia, which resulted in the decrease of ATP production
and deoxidative phosphorylation in mitochondria. Therefore, endo-
toxemia may cause tissue damage due to ineffective use of oxygen and
nutrients. These might enhance the nephrotoxicity of antibiotics.
A study of immune responses to anti-Tamm-Horsfall protein in patients
with chrome active hepatitis associated renal tubular acidosis. J. Yao,
H. Y. Yan, D.C. Dong, Department of Nephrology, RuUin Hospital,
Shanghai Second Medical University, Shanghai, China. Auto anti-
Tamm-Horsfall Protein (THP) IgG antibody in the sera was measured
by ELISA in 11 patients with primary distal renal tubular acidosis
(dRTA), and in 14 chronic active hepatitic patients with (4 cases) or
without (10 cases) dRTA. The value of the antibody level was expressed
as percent of the reference material (mixed sera of 33 normal persons),
that is, 100% = mean of the reference. The coefficients of variation in
test and between tests were 5.99% (N = 10) and 10.0% (N 8),
respectively. The mean antibody level in the normal controls was 98.60
14.90% (means 1 SD). The antibody level was 80.42 17.27% in
primary dRTA, 122.25 8.62% and 111.1 29.39% in chronic active
hepatitic patients with and without dRTA, respectively. The antibody
level was significantly higher in hepatitic patients associated with dRTA
compared with the normal controls (P < 0.05), showing that dRTA
seems to be associated with immune responses to THP. On the
contrary, the antibody level in primary dRTA is significantly lower
compared with the controls (P < 0.05), indicating that the measurement
of anti-THP antibody in the sera may be used for the differentiation
between the primary dRTA and secondary dRTA associated with
chronic active hepatitis.
Complications of percutaneous renal biopsy: An analysis of 930 con-
secutive biopsies. Y.P. Chen, M.H. Li, Division of Nephrology, The
First Hospital, Beijing Medical University, Beuing, China. The com-
plications of percutaneous renal biopsies in 930 cases are analyzed in
this paper. Because modern techniques were used in biopsy localization
and operation, neither accidental puncture to other organs nor second-
ary infection occurred in all cases. However, hemorrhage of renal
wounds was still a predominant complication.
Complicationsa Cases %
Gross hematuria 69 7.4
Severe hematuriab 4 0.4
Perirenal hematomac 43 4.6
Arteriovenous fistula 1 0.1
a No complication was treated with surgical operation. b Requiring
transfusion of more than 1000 ml of blood. C Proven by ultrasonogra-
phy. d Proven by selective renal arteriography and successfully treated
with arterial embolization.
The incidence of hemorrhagic complication in the patients with renal
failure was 31.3%, which was about 3 times higher than 11.3% (those in
patients with normal renal function), 13.8% (with compensatory renal
insufficiency) and 11.4% (with azotimia) (P < 0.01). In this paper the
manifestations, diagnosis and treatment for every renal hemorrhagic
complication are discussed in detail.
Evaluation of renal function by measuring de-electrolyte water clear-
ance. Z.Z. Zhou, J.J. Li, S.F. Wang, et al, Department of Nephrology,
304th Hospital, Beijing, China. The evaluation of renal function by
measuring de-electrolyte water clearance was made for 200 healthy
volunteers and patients. The electric specific conductance of urine
(UES) and serum (SES) was measured by electroconductometer after
urine was collected and serum separated from venous blood. The
osmolarity of urine and serum were measured simultaneously with a
freezing-point osmometer for calculation of free water clearance
(CH2O). The de-electrolyte water clearance (CD.H20) was defined as the
amount of water without electrolytes cleared by the kidney in a definite
time, or the amount of water excreted by the kidney in the process of
excretion of excessive electrolytes in the serum. The calculation of
CDH2O can be represented by the formula:
/ UES
CD.H2O=UX(\l F
where U represents the amount of urine per hour in 24 hrs (ml/hr). For
example, if the U of one person is 100 ml/hr, the UES and SES were
1800 s and 1200 ps, respectively, and the CH2o is —50 mI/hr. The
results showed that CH2O was well correlated with CH2o (r 0.78, P
<0.01). Variance between CDH2O and CM2O only occurred in 6 patients.
It was also observed that the absolute value of CDH2O was 20—30 mI/hr
higher than that of CH2O whether it was negative or positive. Our results
indicated that both CH2O and CDH2O were valuable in the evaluation of
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concentrating and diluting function of the kidney. Their abnormality
appeared earlier than from other common biochemical examinations in
acute renal failure, thus it was helpful to the diagnosis and prognosis.
Renal failure
Protective action of anjsodamine on the Amanita Virosa-induced acute
renal damages in rats. L.S. Liao, Z.Y. Chen, F.H. Yuan, et a!,
Department of Nephrology, Xinqiao Hospital, Chongqing, China. To
clarify the mechanism by which Anisodamine reduces the acute renal
damages caused by Amanita Virosa, 116 adult male Wistar rats were
divided into two groups. Group I rats were gavaged with Amanita
Virosa 2 g/100 g bw. Group II were gavaged with the same amount of
Amanita Virosa plus Anisodamine I mg/l00 g body weight by intraperi-
toneal injection. In Group I, 6 hours after gavage, renal cortex lipid
peroxides (0.41 0.17 mol/g protein) were higher than Group 11(0.34
0.03, P < 0.01). Renal cortex superoxide dismutase activity (77.0
1.9 U/mg protein) and catalase activity (75.8 4.3 K value/g protein)
were lower than Group 11(142.2 3.3, 96.9 7.7, P < 0.01); 12 hours
after gavage, renal cortex Na, K-ATPase activity (2.79 0.11 mmol
Pug protein) was lower than Group 11(3.29 0.44, P < 0.05); 48 hrs
after gavage, urinary protein concentration (7.05 1.47 mg/mI) was
higher than Group 11(5.91 1.38, P < 0.05). Renal proximal tubular
epithelial cells and glomerular podocytes showed damages 6 hours after
gavage under electron microscope and 24 hours under light microscope.
Group II had less severe renal histologic damages. It is suggested that
Anisodamine could protect the kidney against the Amanita Virosa
through its antioxidation.
Mechanism of cordyceps sinensis (CS) in the treatment of aminoglyco-
side induced acute renal failure (ARF). F. Zheng, L.S. Li and J. Tian,
Jinling Hospital, Nanjing, China. To explore the mechanisms of the
therapeutic effect of CS on aminoglycoside induced ARF, we observed:
(I) The influence of CS on serum testerone level in rats and on the
proliferation of rat tubular cells in culture; (2) The influence of CS
treatment on renal cortical Na-K ATPase activity and calcium content
in gentamicin-treated rats; and (3) The influence of CS on malondehyde
(MAD) content in renal cortical homogenate and acid phosphatase of
lysosome (APL) purified from renal cortex after the kenamycin ARF
model was established. The results showed that: (I) CS exerted a
strongly stimulative effect on the proliferation of renal tubular cells; (2)
The use of CS could reduce serum testerone level dramatically; (3) CS
could prevent the decrease of Na-K ATPase activity (0.254 0.074 vs.
0.131 0.07 in controls) and the increase of calcium content (44.07
6.34 ng/g vs. 59.38 8.63 ng/g in controls); (4) CS could attenuate
kidney lipoperoxidation and the detrimental effect of lysosome over-
function. In conclusion, the above results may help explain the thera-
peutic effects of CS on aminoglycoside nephrotoxic ARF.
Protective effect of calcium and verapamil on gentamycin nephrotoxic-
ity. X.K. Xu, T.S. Chen, B. Yang, et a!, Department of Nephrology,
Nantong Medical College, Jiangsu, China. The effects of calcium (Ca)
and verapamil (V) on 22 patients with pulmonary and intestinal infec-
tions who were administered gentamycin (G) 240 mg once daily by i.v.
drip were observed. The average age was 36 years. All patients ceased
to use aminoglycoside or other nephrotoxic agents two months prior to
the study. The primary renal or cardiac disease was excluded. Serum
creatinine (SCr) was normal and urine routine negative. Ca gluconate
100 mg and V 40 mg 3 times daily were given simultaneously for 9 days.
The other 16 patients were treated with G alone as controls. Blood and
urine samples were collected before and at 4, 6, 8, 10 days after the
administration. Results showed that the mean values of Se,, UNAG,
SJ32mG and U/32mG in patients with G + Ca + V presented no
significant change. Sr and UNAG had no change I to 3 days after
administration, but was elevated at the sixth day in 2 patients (9.09%),
being significantly lower than in patients with G alone (P < 0.05). Our
study showed that UNAG was useful in the evaluation of G nephrotox-
icity (NTX) similar to Sr at 81.25%. Sf32mG and UJ32mG were more
sensitive than S to NTX in animal experiments, but in our study they
were closely related to the fever and disease. The mechanism of
protective effect is not clear. Our previous studies in animals revealed
that the renal cortical G and Ca content in rats with Ca or V was lower
than that in rats with G alone.
Percutaneous renal biopsy (PRB) in patients with acute renal failure
(ARF). M.H. Zhao, Y.P. Chen, P. Y. Yu, et al, Division of Nephrology,
The First Hospital, Beijing Medical University, Being, China. The
experience with PRB in 37 patients with ARF of unknown cause
showed that the diagnostic and/or therapeutic changes after biopsy and
pathological examination occurred in 77.3% of the patients. However,
the complications of gross hematuria, perirenal hematoma and renal
arteriovenous fistula after PRB in this group (29.7%) were more
common than those in general patients (12.5%) (P < 0.005). The
incidence of severe renal hemorrhagic complications requiring transfu-
sion of more than 1000 ml of blood (5.4%) was much higher than that in
general patients (0.5%) (P < 0.005). It is suggested that the procedure
should be carefully performed for patients with ARF. Indications and
contraindications of PRB, prebiopsy preparation, puncture operation
and treatment of complications in patients with ARF were discussed in
detail. It is emphasized that renal arteriography should be done for the
patients with persistent or recurrent renal hemorrhage after PRB, and
that selective renal arterial embolization by using autologous blood clot
should be considered before surgical correction of severe hemorrhagic
complications.
A clinicopathological analysis of nephrotic syndrome (NS) with acute
renal failure (ARF). Y.P. Chen, N.M. Zhou, W.Z. Zou, W.Z. Ta and
S.Q. Lit,, Division of Nephrology, The First Hospital, Beijing Medical
University, Beijing, China. Of 247 patients with NS who underwent
renal biopsy in our division, 85 patients had lesions of renal function,
including 25 patients (10.1%) with prerenal azotemia and 15(6.1%) with
ARF due to renal diseases. In this study a clinicopathological analysis
of the latter was done. (1) Acute tubular necrosis (ATN) occurred on
the basis of NS in 3 cases, which resulted from the following causes:
Infective shock due to dysentery in one; gentamycin nephrotoxicity
when it was used for treatment of mastitis in the second; minimal
change disease (MCD) per Se, probably related to renal interstitial
edema. (2) Acute interstitial nephritis (AIN): NS was superimposed by
AIN due to a drug allergy in one. In the other two, a drug allergy
simultaneously caused AIN and NS (MCD in one, and mild mesangial
proliferative glomerulonephritis in another), (3) Glomerulonephritis
(GN): Crescentic GN in 8 cases and endocapillary proliferative GN in
one case, which led to NS and ARF, were confirmed by pathologic
examination. (4) Vascular disease (VD): NS with ARF due to VD was
not found in our series. Effective therapy depends on exact differenti-
ation of underlying diseases which result in ARF. It is emphasized that
renal biopsy is necessary if clinical and laboratory data fail to help the
physician make accurate diagnosis.
Plasma MDA, erythrocyte MDA and SOD in uremic patients. X. I'.
Hou, D.P. Zhai, Department of Internal Medicine, Affiliated Hospital,
Tianjin Medical College, Tianjin, China. We studied the changes of
lipid peroxidation in uremic patients, the plasma malondialdehyde
(MDA), erythrocyte membrane MDA (RBC-MDA), and erythrocyte
superoxide dismutase in 26 chronic hemodialized (CHD) uremic pa-
tients. We also studied the changes of plasma MDA, RBC-MDA and
RBC-SOD in CHD patients during a single hemodialysis, with samples
obtained in pre-hemodialysis (pre-HD), 30 minutes after the onset of
hemodialysis (HD-30) and post-hemodialysis (post-HD), respectively.
The plasma MDA and RBC-MDA levels were significantly (P < 0.05)
higher, RBC-SOD activities were significantly (P < 0,001) lower in both
NHD and CHD patients. There was a positive correlation between
plasma MDA levels and serum creatine (r = 0.492, P < 0.05), and a
negative correlation between RBC-MDA and RBC-SOD (r = —0.573, P
<0.05). During a single hemodialysis, the plasma MDA, RBC-MDA of
CHD patients at pre-HD and post-HD showed no significant change (P
> 0.05). When compared with NHD patients, CHD had a lower plasma
MDA and RBC-MDA levels, although still higher than normal. On the
other hand, CHD patients had a significantly (P < 0.05) higher RBC-
SOD activity at post-HD than pre-HD, although still subnormal. There
was a transient increase in plasma MDA and RBC-MDA levels and a
transient decrease in RBC-SOD activities in CHD patients at HD-30.
There was an increased lipid peroxidation and decreased antioxidation
ability in uremic patients and the severity of the uremic patients and the
severity of the uremic state was related to the disorders. Hemodialysis
could effectively eliminate some uremic toxins affecting lipid peroxida-
tion from plasma, but the endogenic metabolic disorders, which may
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cause the increased lipid peroxidation in uremic patients, were still
persistent despite long regular hemodialysis. The membrane bioincom-
patibility of Cuprophan dialyzer may be one of the causes of the
transient increased lipid peroxidation after the onset of hemodialysis. In
conclusion, there is an increase in lipid peroxidation and a decrease in
anti-oxidation in uremic patients, so SOD might be useful in clinical
practice.
Possible role of oxygen-derived free radical and antioxidant system in
the pathogenesis of chronic renal dysfunction. D.K. Qi and J.H. Wang,
Department of Cardiorenal Medicine and Research Institute of Sur-
gery, Third Military Medical College, Chongqing, China, To evaluate
the possible role of oxygen-derived free radical injury in the pathogen-
esis of chronic renal dysfunction, plasma LPO (lipid peroxides) and
activity of SOD (superoxide dismutase) in erythrocytes and plasma
were measured with TBA method and chemiluminescence, respec-
tively, in thirty normal subjects and thirty patients with renal disease
(ten nephritis patients with normal renal function and twenty patients
with chronic renal dysfunction). Statistical analysis revealed that eryth-
rocyte and plasma level of SOD was decreased linearly with the
elevation of plasma BUN and Cr suggesting that oxygen-derived free
radicals and lipid peroxidative injury may play roles in the development
of nephritis and chronic renal dysfunction. In patients with chronic
renal dysfunction the antioxidant ability was decreased, oxygen-de-
rived free radicals were accumulated and led to renal tissue damage,
finally resulting in renal failure.
Changes of deformabiity and membrane stability of red blood cells
(RBC) in patients with end-stage renal disease (ESRD) and hemodialysis.
G. W. Jiang, Department of Nephrology, Chinese Great Wall Hospital,
BeUing, China. RBC deformability and membrane stability were mea-
sured in ESRD patients with and without hemodialysis (HD) and
normal controls using laser diffractometer. The deformability (Al) and
membrane stability (A2) of RBC in ESRD patients without HD were
significantly reduced as compared with the levels in normal controls as
well as in patients with HD (see table below).
N Al A2
Controls 17 1.96 0.03 1.36 0.07
ESRD without HD 17 1.56 O.04 0.97 o.o5
ESRD with HD 29 1.80 0.07' 1.98 0.04"
a P < 0.01 vs. controls "F <0.01 vs. ESRD without HD
The blood viscosity measured by cone-plate viscosimeter and hemato-
crit (Hct) were significantly decreased in ESRD patients before HD, but
dramatically increased after HD (see table below).
Hct
Total blood viscosity
Low shear rate High shear rate
Controls 43.6 1.56 13.14—16.41 5.62—6.39
ESRD
before HD 20.9 0.71 9.67 0.71 4.06 0.29
afterHD 22.3 1.34 12.53 1,05 5.67 o.Sla
a P < 0.01 vs. ESRD before HD
Our results showed that the deformability and membrane stability of
RBC and the blood viscosity in ESRD patients were obviously im-
proved by HD. These changes may be attributed to the correction of the
pathologic condition, such as acidosis, water-electrolyte imbalance and
the correction of increased oxygen radicals in ESRD patients by HD.
Study on anion transport across the erythrocyte membrane in uremic
patients. H.F. Feng, X.J. Zhang, L.T. Lun, et al, Department of
Internal Medicine, Xinhua Hospital, Shanghai Second Medical Uni-
versity, Shanghai, China, The anion transport across the erythrocyte
membrane (ATAEM) in 19 uremic patients was studied. It was found
that the time of NO2 transport across the erythrocyte membrane in
uremic patients was increased as compared with controls. The time for
ATAEM determined in 10 healthy controls was 28.0 4.1 seconds. The
results of ATAEM in uremic patients were as follows: (1) 60.7 12.7
seconds in uremic patients (N = 9) not treated with dialysis, were
significantly slow as compared with controls (P <0.01); (2) 51.7 11.38
seconds in uremic patients treated with hemodialysis (N 5), were
significantly slow as compared with controls (P < 0.01); (3) 29.02 4.24
seconds in uremic patients treated with peritoneal dialysis (N = 5)
showed no significant change as compared with controls (P > 0.05).
There was a statistically significant correlation between ATAEM and
BUN (r = 0.63; P < 0.01). It is suggested that the abnormality of NO
transport across the erythrocyte membrane in uremic patients should
probably be due to a damage of extracellular domain of band 3 protein.
The fact that the slowed ATAEM in uremic patients was improved by
peritoneal dialysis, but not by hemodialysis, suggested that peritoneal
dialysis should protect band 3 protein.
The changes of serum lipid in uremic patients. H.M. Lou, P.D. Ma,
H.I. Yan, The Yunnan Provincial People's Hospital, Kunming, China.
The aim of this study was to investigate the changes in concentrations
of cholesterol, triglyceride, /3-lipoprotein, high-density lipoprotein cho-
lesterol (HDL-cholesterol), HDL2-cholesterol and HDL3-cholesterol in
serum of uremic patients. Forty-five nontreated uremic patients (21
males, 24 females) were studied. The concentration of creatinine in
serum was 226 to 1320 mol/liter (mean 523.4 mol/liter), and creati-
nine clearance was <25.0 mllmin (mean 13.1 mI/mm). The results are
summarized as follows:
Patients Normal subjects
Cholesterol mmollliter 4.89 2.08 4.40 1.60
Triglyceride mmol/liter 2.53 1.85k 1.18 0.68
HDL-cholesterol mmol/liter 0.97 0.25 1.44 0.65
HDL2-cholesterol mmol/liter 0.51 0.18 0.49 0.31
HDL3-cholesterol mmol/liter 0.46 0.23a 0.85 0.36
/3-lipoprotein g/liter 0.33 0.11 0.31 0.08
Data are mean SD. a P < 0.01, as compared to normal subjects.
The results suggested that the triglyceride should be increased, and the
HDL-cholesterol and HDL3-cholesterol decreased. Thus, the hyper-
triglyceridemia and low high-density lipoproteinemia might induce the
renal arteriosclerosis to aggravate the renal iijury and increase the
complications of cardiovascular disease.
The activity of plasma prekallikrein-kallikrein system in patients with
chronic renal failure. B. Zhang, Z.Q. Li, E.H. Chen, The First Affiliated
Hospital of China Medical University, Shenyang, China. The activity
of plasma prekallikrein (PK), prekallikrein activator (PKA), and kal-
likrein (Ka) were measured by chromogenic substrate H-D-Pro-Phe-
Arg-pNA (S2302) in 38 patients with chronic renal failure (CRF). The
relationships between hypertension and the activity of PK, PKA and
Ka were observed. It was revealed that the activity of PK was
significantly lower in patients with CRF than that in normal subjects (P
<0.01). PKA and Ka had no significant difference in these two groups.
The activities of PKA and Ka were higher in CRF patients with
hypertension than in those with normal blood pressure (PKA: P < 0.05,
Ka: P < 0.05). The activities of PK were lower in CRF patients with
hypertension than in those with normal blood pressure, whereas this
difference was not statistically significant. A significant positive corre-
lation was found between PK and serum creatinine in CRF patients.
The results showed that plasma PK activity was decreased in CRF
patients. The plasma prekallikrein-kallikrein system (PKKS) was acti-
vated in patients with CRF complicated renal hypertension. The
activation of PKKS that was marked by the decrease of PK and the
increase of PKA and Ka, may lead to a decrease of blood pressure
theoretically. Therefore, the activation of PKKS may be the compen-
satory mechanism of CRF complicated renal hypertension.
Alterations of serum hyaluronic acid (HA) in patients with chronic
renal failure (CRF). Z.L. Qiu, J. Y. Wu, The First People's Hospital of
Nantong, Jiangsu, China. This paper reports that serum HA in 14 cases
with CRF was determined with RIA method; the alterations of 10 cases
before and after hemodialysis were observed and the comparative
analysis with serum HA in 110 cases of healthy elderly patients was
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carried out. The results were shown as: I) Serum HA in the healthy was
on an average of 29.65 16.56 (10.6—60.8) gIIiter; 2) Serum HA in
CRF group was on an average of 197.50 127.75 (45.1—470.2) Wliter,
evidently higher than in control group (P < 0.01; t = 13.28; 3) Serum
HA in all patients showed a decrease after hemodialysis, an averaging
decrease by 32.2%, having a remarkable difference in Serum HA titre
between before and after hemodialysis (P < 0.01; t = 4.031; 4) Serum
HA in CRF group and 5Cr indicated an obviously normal correlation (r
= 0.781, P < 0.01). It can be concluded that: (1) There is a severe
damage in glomeruli and a decreased excretion of micromolecular HA
in cases with CRF, and also the toxic products of metabolism (such as
guanidine, phenols, amine and urea) directly damage the hepatic
endothelial cells and cause hepatic deficient decomposition. They can
also stimulate Leydig's cells to increase HA synthesis and, thus, result
in an apparent increase of serum HA in cases with CRF; (2) The more
seriously the renal function damaged in cases with CRF, the higher the
serum HA increased, suggesting that serum HA is the sensitive symbol
for the progressive renal damage, and (3) micromolecular HA can be
excreted through dialyzers.
Clinical significance of determination of anti-platelet associated anti-
bodies in patients with chronic renal failure. S.F. Zheng, Y. Xiong, D.K.
Zhou, et al, Red Cross Hospital of Shenyang, China. The results of
anti-platelet associated antibodies IgG (PAIgG) in 25 patients with CRF
(17 males and 8 females, aged 21—55 years) induced by primary
glomerulonephritis were analyzed preliminarily. The reagent of PAIgG
was introduced using enzyme linked immunosorbent assay (ELISA).
The counts of platelet aggregation reaction to ADP and epinephrine,
PAIgG in patients with CRF were: 108.0 12.0 109/liter, 43.0
21.5%, 108.6 26.4% and 46.3 19.7 ng/107 PA in azotemia, 86.3
36.5 l09/liter, 24.2 18.3%, 54.5 12.2% and 62.4 46.8 ng/l07 PA
in uremia, respectively. The platelets of patients with CRF decreased
slightly and the aggregation of platelets had a variety of damage in
uremia. Clinically there was a decrease in platelets and aggregation.
The accumulation of blood toxins in patients with CRF led to some
changes in agent of membrane of platelets and produced antibodies
inducing CIC and specific or nonspecific reaction of the FC segment of
IgG. The concentration of plasma PAIgG was marked in patients with
CRF (P < 0.01); the counts of platelets decreased slightly. After
hemodialysis, PAIgG was decreased, but was markedly higher than that
of the control group. The decrease of platelets which produced auto-
antibodies or allogenic antibodies resulted in the increase of PAIgG
level. PAIgG level in patients with CRF may be considered an impor-
tant index for bleeding and curative effect.
The concentrations of tumor necrosis factor-alpha (TNFa) in serum
and peripheral blood lymphocytes in patients with end-stage renal dis-
eases (ESRD). L.F. Yu, et at, Department of Nephrology, Chinese
Great Wall Hospital, Beijing, China. TNFa as a potent cytokine
produced by macrophage may play an important role in human immune
response. The concentration of TNFa in serum and 2 X 106 peripheral
blood lymphocytes (PBL) stimulated by PHA in normal controls and in
ESRD patients was determined by Elisa assay (with TNFa monoclonal
antibodies T5 and E6). TNFa concentrations were calculated by
recombinant TNFa standard curve. Results show that seral TNFa
content was significantly decreased in ESRD patients compared with
normal controls, while the supernatant TNFa contents in PBL of ESRD
patients did not change significantly. These results suggest that ESRD
patients were immunodeficient in macrophage.
Study on T-lymphocyte transformation and interleukin-2 activity in
patients with chronic renal failure. L. Ma, H. Gu, Y.Z. Dong, Second
Clinical College, Norman Bethune University of Medical Sciences,
Changchun, China. Recently, the cellular immunodeficiency of chronic
renal failure (CRF) is regarded as relating to the failure of T-lymphocyte
transformation and interleukin-2 (IL-2) production. To evaluate the
function of cellular immunity in CRF relating to T-lymphocyte trans-
formation and IL-2 activity, the T-lymphocyte transformation and IL-2
production in 40 patients with CRF were investigated. Both T-lympho-
cyte transformation and IL-2 production were significantly decreased in
patients with CRF (N = 40, 23385 2367 cpm and 75.6 8.1 U/mI) as
compared to normal controls (N = 30, 33215 3884 cpm and 179.4
14.8 U/mI). It was suggested that in patients with CRF, there should
exist a decrease and depression of function in cellular immunity. Our
results indicated that the cell-mediated immune response is defective in
the CRF patients. It is unclear whether the immunodeficiency is due to
the function deficiency of T-Iymphocyte or the relative change of
proportions and absolute number of T-lymphocyte subsets. Further
study is needed to clarify this question.
Effects of ketoacids on protein metabolism, PTH levels and progression
of CRF in predialysis patients. FL. Zheng, Z.Q. Bi, S.F. Du, et al,
Renal Division, Department of Medicine and Clinical Nutrition, OYMC
Hospital, Beijing, China. The effects of low protein diet (LPD) supple-
mented with ketoacids (KA) on azotemia, nutritional status (plasma
amino acids, serum albumin, nitrogen balance), serum iPTH, Ca and Pi
levels and changes in GFR were studied in predialysis patients (N =
22). The initial serum creatinine (SCr) levels and GFR, measured with
99Tc-TDPA method, were 4.2 2.4 mg/dl and 18.8 4.4 mI/mm,
respectively. The patients were administered LPD (0.42—0.45 g/kg/day)
plus KA (0.12—0.15 g/kg/day) for 10—24 months. After 6—10 weeks of
treatment with the regimen, BUN and serum Pi levels decreased
markedly, while plasma essential amino acid levels, nitrogen balance
and serum Ca levels were improved. S and serum albumin levels were
not changed markedly. Serum iPTH level was reduced from 36.6 7.9
ng/ml to 23.8 4.4 ng/ml (P < 0.01) 3 months later and 31.6 10.3
ng/ml (P > 0.05) 10 months later. After 12.6 2.8 months in 12 cases,
the average rate of decrease in GFR was lower (0.19 mI/mm/month)
than that before this regimen (0.4 mI/mm/month, observation of 10.2
4.0 months). The results showed that KA therapy may improve protein
metabolism and suppression of PTH, and probably retard progression
of CRF.
Microencapsulated products of bacterial enzymes used in treatment of
chronic renal failure. Q. Y. Zhang, S. Y. Chen, J.Q. Qian et a!, Renal
Division, Renji Hospital, Shanghai Second Medical University, Shang-
hai, China. This paper reported the results of treatment of patients with
chronic renal failure (CRF) by using microencapsulated products of
bacterial enzymes in 10 patients with low salt, low protein and high
carbohydrate diet for over one week, with the serum creatinine higher
than 442 smol/liter (5 mg/dl). They consisted of 3 males and 7 females,
with an age range of 36—59, average 47.9 years. The microencapsulated
products of bacterial enzymes (containing urease 40%, creatininase
60%) were given P0 with a dosage of 0.5 g/kg body weight per day in the
first and second day, and in the third day, 1 g/kg body weight per day.
After one week, two of the 10 patients repeated the microencapsulated
products of creatininase for another 3 days as above. The results are
shown in the following table.
Before treatment After treatment
BUN Cr BUN Cr
N (mol/liter) (mol/liter) (rmol/liter) (lLmol/Iiter)
1 33.6 1626.6 34.3 1485.1
2 26.6 1281.8 21.8 1193.4
3 20.7 998.9 22.5 945.9
4 20.7 1037.9 24.6 512.7
5 11.8 663.0 17.5 636.5
6 8.6 724.9 12.1 680.7
7 13.6 928.2 12.8 866.3
8 25.3 795.6 25.3 786.8
9 21.9 1432.1 18.2 1352.5
10 24.6 972.4 24.3 937.2
In essence, 4 cases had BUN decrease 4—17%, but the other 6 had no
change, or even had an increase. However, serum creatinine was
decreased an average of 10% in all. Two patients taking a second course
of enzyme treatment had serum creatinine decrease 10—16%, and totally
serum creatinine decrease 16—23% after two courses of such therapy.
Production of bacterial enzymes (including urease and creatininase)
and its use in treatment of experimental renal failure. P. Zhang, Q. Y.
Zhang, J.Q. Qian, Renal Division, Renji Hospital, Shanghai Second
Medical University, Shanghai, China. Bowel therapy for uremia has
been investigated widely. In our previous studies the production and
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use of bacterial urease had been carried out. In the present study, we
used creatinine as a substrate to culture certain bacteria for producing
creatininase. By way of orthogonal design, we selected the best culture
conditions of corynebacteriuni glutamicum to produce creatininase.
The creatininase can decompose about 50—70% creatinine in this
condition. After microencapsulation, about 40% of the original creat-
ininase activity is retained, ready to be used. The animal model was
made by the ligation of bilateral renal pedicles of male Wistar rats. We
divided the rats into three groups. Group A was treated with creatini-
nase alone, and Group B was treated with creatininase and urease,
while Group C as a control group received no treatment. Our data
showed that the creatininase microcapsulated products can significantly
decrease the serum creatinine in uremic rats (P < 0.05). The levels of
serum creatinine and BUN were decreased significantly (P < 0.05)
while the rats were treated with creatininase and urease jointly, but not
in the control group. In the control group, the levels of serum creatinine
and BUN remained unchanged or increased continuously. In conclu-
sion, bacterial enzymes (including urease and creatininase) may have a
potential adjunctive efficiency in uremia treatment.
Observation on therapeutic effect of Shenshuai No. 1 in treating 50
cases of chronic renal failure (CRF). J. 1'. Zhou, M. Huo andH.Z. Wang,
Kidney Division, Department of Internal Medicine, Guang An Men
Hospital, China Academy of Traditional Chinese Medicine, China.
This paper presents an analysis of 50 cases of CRF treated mainly by
Shenshuai No. 1, combining Chinese herbs and Western medicine. Of
the 50 cases, 44 showed marked improvement and 6 no improvement,
with an effective rate of 88%. The survival time was one year in 5 cases,
two years in 12, five years in 19 and more than five years in 14. The
effect of Shenshuai No. I in reducing BUN level showed a close
relationship with the primary diseases but no relationship with the
severity of renal failure. The present study also suggests that the
combined administration of Chinese herbs and Western medicine
showed promising results in relieving symptoms of CRF. However, no
marked results could be expected in treating patients with chronic
nephritis complicated with hypertension and late-stage renal failure.
The authors attribute the satisfactory results to correct diagnosis in
traditional Chinese medicine and its principles of treatment.
Treatment of chronic renal failure with Oenothera Biennis L in rats.
Z.Q. Bi, Y.H. Bo, J.H. Duan, et al, Division of Nephrology, PUMC
Hospital, Being, China. Polyunsatured fatty acids (PUFA) may be
responsible for the nonimmune regulation mechanism of chronic renal
failure (CRF). It was reported that PUFA could help to preserve renal
function in CRF rats, To test this hypothesis, we studied the effect of
orally administered Oenothera Biennis L (OBL) on CRF in the partially
nephrectomized rats. OBL containing 75% linoleic acid and 7—9%
r-linolenic acid was produced in northeast China. As compared with the
control group, the groups treated with OBL showed the following
features: (1) Reduced urine protein excretion (P < 0.05); (2) Decreased
level of serum cholesterol in the group treated for 90 days (P <0.001);
(3) Similar S. level as before treatment; (4) Increased levels of PGF1
and PGE2 both in renal cortex and medulla; (5) Increased 6-Keto PGFI
in the cortex; (6) Undetected alteration of TXB2 level; (7) Less injury to
glomeruli than the control (P < 0.05). It is concluded that OBL has a
beneficial effect on remnant and may be useful as a conservative
treatment of CRF.
The long-term effects of rhubarb on preventing progression of chronic
renal failure (CRF). J.H. Zhang, L.S. Li, Jinling Hospital, Nanjing,
China. A clinical trial to evaluate the effects of rhubarb, a Chinese
herbal medicine, on CRF was conducted. 148 patients with initial S.
levels of 328.0 83.1 mol/liter were divided randomly into three
groups: Rhubarb treated group, rhubarb + Captopril group and the
control group. During the 6—48 months of treatment, all the patients
were on a low protein and low phosphorus diet. The results showed that
the progression rate of renal failure, calculated by regression analysis of
l/Scr versus time, was found to be slowed down after the administration
of rhubarb. Sr levels were kept stable and BUN, BUN/SC. ratio fell
down during the follow-up period. Uremic symptoms were ameliorated
with the best results obtained in rhubarb + Captopril group. The effects
of rhubarb on protein metabolism and thyroid function are of great
importance in treating CRF. It is concluded that rhubarb is beneficial to
CRF. The regime of rhubarb and Captopril is a preferable choice in the
long-term treatment of preventing progression of CRF.
Recombinant human erythropoietin (rIluEPO) in treating anemia in
predialysis chronic renal failure (CRF). Q.W. Wang, L.S. Li, Jinling
Hospital, Nanjing, China. In order to assess the effect of rHuEPO in
anemia in azotemic patients who do not require dialysis, a 10 month
study was conducted with 54 patients, 33 males and 21 females, with
mean serum creatinine levels of 512.7 300.5 mol/liter and mean
hematocrit (HCT) of 25.1 5.6%. Thirty patients had glomerular
disease (GN), and 19 had interstitial nephritis (TIN). rHuEPO was
given 50—100 U/kg three times a week subcutaneously. Forty-six
(85.2%) of the patients achieved target HCT in 3 months. The mean
HCT in the GN group increased from 24.5 5.3% to 36.7 6.2% in 2
months, while the TIN group increased its mean HCT from 26.5 5.3%
to 35.2 4.1% in 3 months. The thyroid function was observed in 11
patients pre- and post-rHuEPO treatment, The results are listed in the
table.
Pre-EPO
Post-EPO (month)
1 2 3
T3 (ng/ml) 0.9 0.23 1.3 0,31b 1.0 0.39 0.9 0.35
T4 (tg/dl) 8.8 2.9 11.8 2.8a 8.6 2.4 9.0 0.35
TSH (mm/liter) 4.8 1.9 7.1 2.5 5.9 2.8 5.1 3.0
r-T3 (pg/liter) 92 24 69 31 76 29 78 30
a p < 0.05; b P < 0.01 vs. pre-rHuEPO
It is concluded that treatment with low-dose rHuEPO in non-dialysis
patients with CRF is safe and effective. Better results can be obtained
in TIN patients than in those with GN. The quality of life is improved
in patients on rHuEPO, which might relate with the change of thyroid
function.
Value of the 9smTc.methylene diphosphonate bone scan in renal osteo
dystrophy. G. Y. Wang, P. Zhu, C. V. Shi, SE. Wang, D.C. Dong, TX.
Zhang, J.L. Xu, and C.M. Zhu, RuUin Hospital, Shanghai Second
Medical University, Shanghai, China. Osteopathy is common in pa-
tients with uremia, but its diagnosis remains difficult. In this study, each
patient received 0.3—0.4 mCi/kg of mTcmethylene diphosphonate
(MDP) intravenously. The study included 24 patients with uremia, and
iliac bone biopsy and roentgenographic findings were obtained in each
patient. Ten additional patients with azotemia and 25 normal subjects
served as controls. All 24 patients with uremia had pathological features
of renal osteodystrophy. Osteopathy due to secondary parathyroidism
was observed in 11(45.8%) patients, osteonialacia in 4 (16.6%), and
mixed in 9(37.6%). Twenty-three of the 24 patients with uremia (95.7%)
and 3 of 10 patients with azotemia had positive ssmTcMDp bone
scanning (P < 0.01). The latter was not correlated with age, sex and
cause of renal failure, but may be related to pathological types of
osteodystrophy. In osteopathy due to secondary parathryoidism, there
was a tendency of increase in mTcMDP uptake in the soft tissue,
whereas patients with osteomalacia often had a high tracer uptake in the
bone and those with mixed osteopathy showed an increase of tracer
uptake in both bone and soft tissue. Repeated 9smTcMDp bone scan
examinations demonstrated that the scintiphotographic changes were
closely related to the status of the disease. After renal transplantation,
improvements were made in both the osteopathy and the bone scan.
The study indicates that 99"Tc-MDP bone scan is a non-invasive,
reproducible and accurate method in the diagnosis and evaluation of
severity of renal osteopathy.
Aluminum and renal osteodystrophy. P. Zhu, G. Y. Wang, Y.F. Vu, et
al, Division of Nephrology, Ruijin Hospital, Shanghai Second Medical
University, Shanghai, China. To evaluate the relationship between
aluminum (AL) and renal osteodystrophy, 51 uremic patients (HD 37,
CAPD 4, nondialysis 10) were studied, Mean age was 45.54 years (from
20 to 68 years). Iliac bone biopsies and bone AL staining were done in
all the cases. In 27 of the 51 cases, serum iPTH (C-terminal) and
l,25(OH)2D3 levels were measured by RIA. Serum AL and bone AL
contents were measured by atomic absorption spectrophotometry.
Serum Ca levels were detected and bone sections were stained with HE
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Masson, Von-Kossa, Toluidine-blue and Aluminon (rosolic acid). The
incidence of renal osteodystrophy was 100%. Bone disease can be
subdivided into three types according to the histologic changes: Pre-
dominant hyperparathyroid bone disease (Type 1) 26; low turnover
uremic osteodystrophy (Type 2) 4; and mixed uremic osteodystrophy
(Type 3) 21. The positive rate of bone AL staining was 11.7% (N = 6),
being highest in Type 2. Serum AL and bone AL contents were
significantly higher than the controls in the three types of renal
osteodystrophy on HD. Bone AL contents were correlated with the
duration of HD(N = 21, r = 0.704, P <0.001), and the serum calcium(N = 27, r = 0.341, P < 0.05), but not with the serum levels of iPTH,
1 ,25(OH)2D3 and AL. The duration of HD and bone AL contents were
markedly longer and higher in the bone AL staining positive group than
that of the negative group (P < 0.001, respectively), however, the
serum AL levels were not significantly different between the two
groups. Our data suggested that: (1) AL accumulation in bone was
related to duration of HD; (2) AL may play an important role in the
intervention of bone mineralization.
The significance of quantitative analysis of whole body bone Scintipho-
tography (WBBS) in renal osteodystrophy. D.P. Zhai, L.C. Yang, et al,
Department of Internal Medicine, Affiliated Hospital of Tianjin Medical
College, Tianjin, China. The quantitative analysis of WBBS was
performed on 45 control subjects (20 males and 25 females, aged 18—64
years) and 16 patients (6 males, 10 females, aged 17—54 years; CGN 10
cases, RTA 4 cases, polycystic kidney 1 case, Fanconi's syndrome 1
case) 3 hours after intravenous injection of mci mTcMDP, using
Gemini-700 SPECT system with MCS-560 computer. The results reveal
that 16 WBBS patients were abnormal, while X-ray showed abnormal
changes for only 10 cases. WBBS showed 47 pseudofractures in 5
patients, but bone radiography showed 5 pseudofractures in 2 patients.
So, WBBS is superior to bone radiography in detecting early renal
osteodystrophy and pseudofracture. Yellow tracer uptake was dynam-
ically observed in all 4 cases. It suggests that the bone turnover of
patients starts to increase, but not any changes on bone radiography. In
conclusion, the quantitative analysis of WBBS may be a valuable
routine method for early diagnosis, differential diagnosis, and evalua-
tion of the therapeutic effects of renal osteodystrophy.
Changes of PTH,1,25(OH)2D3 and biochemistry in renal osteodystro-
phy. J.K. Jia, DX. Lou, B. Zhu, G.Y. Wang, H.T. Chao, and D.C.
Dong, Renal Unit, Second Hospital, Zhejiang Medical University,
Hangzhou, Renal Unit, Ruijin Hospital, Shanghai Second Medical
University, Shanghai, China. The changes of plasma PTH,
I ,25(OH)D3, serum calcium, phosphorus and AKP were observed in 55
uremic patients with renal osteodystrophy. The results showed that: In
all types of renal osteodystrophy, plasma PTH was markedly higher
than normal (P < 0.001), while plasma 1 ,25(OH)2D3 and serum calcium
were lower than normal (P < 0.001). In low bone-turnover uremic
osteodystrophy (LTO), plasma phosphorus was markedly lower than
that of high bone-turnover uremic osteodystrophy (HTO) and mixed
uremic osteodystrophy (MO) (P < 0.05), and plasma I ,25(OH)2D3 was
significantly lower than that of HTO (P < 0.05). In HTO and MO, serum
phosphorus was much higher than normal (P < 0.001). Plasma PTH had
a negative linear correlation with plasma 1 ,25(OH)2D3 (P < 0.05), a
positive linear correlation with serum AKP (P < 0.05), but no linear
correlation with the duration of hemodialysis, serum calcium, serum
aluminum and bone aluminum content. Plasma 1 ,25(OH)2D3 had no
linear correlation with duration of hemodialysis, serum phosphorus,
serum aluminum and bone aluminum content. There was no significant
difference in the plasma PTH, 1 ,25(OH)2D3 and serum AKP between
the bone aluminum stain negative and positive groups.
Clinical analysis on bone metabolism of patients with chronic renal
insufficiency. S.D. Zhu, L. Zhang, Q.Q. Yang, X.X. Bian, Z.H. Meng,
Y.X. He, and G.R. He, Department of Internal Medicine, Beijing Ji
Shui Tan Hospital, Beijing Institute of Traumatology and Orthopedics,
Beijing, China. Ca, P, AKP and BGP in blood, as well as Ca, P and
hydroxyproline (HOP) in urine, were measured in 32 cases with chronic
renal insufficiency (CRF) (19 males, 13 females), along with analysis on
X-ray film, single-photone absorptiometry (SPA) and dual energy X-ray
absorptiometry (DEXA) of lumbar vertebrae. Increased in 10 of the 30
cases (positive rate 33.3%). Serum AKP increased in 3 of the 31 cases
(positive rate 9.7%). Twenty-four hour urine HOP increased in 5 of 27
cases (positive rate 18.5%). X-ray films of lumbar vertebrae demon-
strated osteoporosis in 11 (positive rate 35.5%). Of the 26 cases who had
SPA measured on the left ulna and radius, 12 had lower bone mineral
contents (BMC) and BMD than the normal (positive rate 46.2%).
DEXA was also adopted in 26 cases, BMD decreased in 11 and
increased in one (positive rate 53.8%). In the 21 cases of CRF, X-ray of
lumbar vertebrae, SPA, DEXA were measured in the same stage, and
the positive rates were 33.3%, 42.9% and 57.1%. In our 27 patients with
CRF, HOP results are easily changed by diet components or collagen
components in diet. BGP is a kind of synthetic product of osteoblasts
and secreted by them, so BGP can reveal bone transformation rate, and
therefore bone metabolism. X-ray is of limited value both in specificity
and sensitivity when making diagnosis of renal osteopathy and in
determining the characteristics of osteoporosis. SPA is capable of
detecting the density of peripheral cortex, but fails to detect that of
cancellous bone, thus it is less sensitive in early diagnosis. The authors
believe that DEXA can be used for the detection of BMC in any part of
the skeleton; it is rather sensitive in diagnosing osteoporosis. However,
the patients of our group were of azotemia or uremia, and so the
sensitivity of DEXA in diagnosis might have been affected. It is
suggested, in order to pursue early diagnosis of renal osteopathy,
measurement of DEXA be adopted in compensatory phase of CRF and
performed regularly.
Pathological analysis of renal osteodystrophy. Y.F. Yu, and Y.X. Hu,
Department of Pathology, Shanghai Second Medical University,
Shanghai, China. Fifty-one patients with chronic renal failure were
studied. The bone biopsies of all patients were obtained with a drill of
stainless steel from a site on the iliac crest. The specimen consisted of
cortical bone and trabecular bone about 0.5 x 0.5 x 1.5 cm. The
biopsies were fixed in 40% alcohol, embedded in methylmethacrylate
and then longitudinal sections 5 z thick were cut with tungsten carbide
knife and by Jung microtome. The sections were stained with HE,
Masson, Toluidine blue, Vonkossa, Rosolic acid and examined by
microscope. Histological bone changes are characterized by osteitis
fibrose, increased resorption of bone, increased osteoid volume, active
remodeling of bone and aluminum deposition in bone. Osteitis fibrosa
includes the presence of increased bone resorption and endosteal
fibrosis. Increased osteoid volume includes two forms: Increased
osteoblastic activity and a relative absence of cell activity. Active
remodeling included both increased osteoblastic activity and osteoclas-
tic activity, active mineralization and bone formation. Aluminum de-
posits were frequently observed at the interface of osteoid and miner-
alized bone, along the trabecular surface. Histologically, advanced
renal bone disease can be subdivided into three groups. Type I, 26 cases
(50.98%), secondly hyperparathyroid bone disease, osteitis fibrosa and
active remodeling of bone are the most frequent lesions observed; it
reflects the presence of secondary hyperparathyroidism. It is clear that
parathyroid gland stimulation initially occurs because of hypocalcemia
resulting from phosphate retention. This type is called high-turnover
uremic osteodystrophy. Type 114 cases (7.48%), osteomalacia, with the
presence of large acellular osteoid deposits, decreased mineralization
and bone formation, this type is called low-turnover uremic bone
diseases; it reflects the disturbance in metabolism of vitamin D. With
advancing renal insufficiency, the kidney loses the ability to synthesize
1 ,25-dihydroxy vitamin D. Type III 21 cases (41.18%), mixed uremic
osteodystrophy, osteitis fibrosa is associated with both increased Os-
teoid volume and a mild decrement in mineralization activity. Six
showed aluminum positive reaction in the bone tissue. Even though
these groups do not represent fully separate entities, and transformation
from one form to another can occur, it is useful to distinguish them
since therapy can be tailored according to the predominant histologic
findings.
Effects of zinc supplement on immunological functions of patients with
chronic renal failure. MB. Li, Y.C. Fang, Y.Z. He, et al, Department
of Internal Medicine, Guangxi Medical College, Instrumental Analysis
and Research Center of Guangxi, Nanning, China. Previously, we
reported that the levels of Zn in chronic renal failure (CRF) patients
were lower than those of normal control, and that after the supplement
of zinc, the levels of Zn, Se and Co in the serum and hair of the CRF
patients increased significantly. To investigate the effects of zinc
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supplement on the immunological functions of CRF patients, 33 pa-
tients were given zinc gluconate 140 mg (containing Zn 20 mg) orally
three times daily. The duration of the course of treatment was 46 weeks.
Before the supplement of zinc, the levels (mg/liter) of lgG, IgA, 1gM, C3
were 8877.58 4744.86(X SD), 1883.33 1176.89, 1542.12 766.36
and 1073.30 78.63, respectively. After the supplement of zinc, their
respective levels were 11292.12 6076.99 (P < 0.05), 2429.09
1775.70 (P > 0.05), 2178.79 1424.47 (P < 0.05), 1307.72 478.48 (P
< 0.05). Before zinc supplement, the results of erythrocytes rosette
formation test (ERFF) and lymphocyte transformation test (LTT) were
43.06 11.53% and 68.21 15.43%, respectively. But after zinc
supplement, the respective results were 49.58 15.40% (P < 0.05) and
79.09 9.57% (P < 0.01). In the control group, the levels and results of
IgG, IgA, 1gM, C3, ERFT and LTT before and after zinc supplement
did not change significantly (P > 0.05). Our results also showed that
zinc supplement remarkably decreased the infectious rate in the CRF
patients (decreasing from 56.6% to 14.07%).
Blood purification
High-flux dialysis (HFD) with polysulfone (PS) membrane China-made
hemofilters. X. Y. Wang, C. Y. Xing, G. Y. Huang, et at, Department of
Nephrology, The First Affiliated Hospital of Nanjing Medical College,
Nanjing, China. We studied the effects of HFD with PS membrane
hemofilters instead of Duo-flux C-DAK dialyzers to treat patients with
end-stage renal disease. Three kinds of dialyzer were used: In Group A,
20 times HFD with PS membrane hemofilters (YT-1 10, surface 1.1 m2),
there were 14 patients (13 men, I woman, average age 45.7 15.6
years, range 21—81 years), in whom I patient had anaphylactoid
reaction, 1 angina pectoris, 3 vomiting, 3 heart failure, and 2 hypoten-
sion during the standard hemodialysis (HD). The blood flow rate was
300 mI/mm, and bicarbonate dialysate flow rate was 800/mm. The
dialysis time was 3 hours per time, 2—3 times per week, In Group B, 17
times HFD with Duo-flux C-DAK dialyzers (surface 1.2 m2) (USA),
other technical conditions were similar to those of Group A. In Group
C, 20 times HD with cuprophan membrane dialyzers (surface 1.2 m2),
the blood and acetate dialysate flow rate was 250 mI/mm and 500
mi/mm, respectively. Ultra-filtration of each patient in all groups was
about 2—3 kg per time. No side effects were found in Group A. We
conclude that the effects of HFD with both YT-1 10 and Duo-flux
C-DAK dialyzers are similar, and they are more effective than those of
HD with cuprophan membrane dialyzers. YT-1 10 hemofilters can
impact Duo-flux C-DAK dialyzers on HFD.
Observation on hemodynamics and hemorrheology in uremic patients
with maintenance hemodialysis. H.W. Zhu, L.P. Wen, H.F. Feng, eta!,
Department of Internal Medicine, Xinhua Hospital, Shanghai, China.
This study was designed to investigate the effect of hemodialysis
duration on cardiovascular function and microcirculation. Hemodialy-
sis (HD) was examined in 30 patients with chronic renal failure, using a
cardiovascular function detecting instrument. The results showed that
stroke volume (SV), cardiac output (CO) and cardiac index (CI) in 20
cases who had been treated with HD for less than 4 months (G) were
significantly lower than in the other 10 cases who had HD more than 1
year (C). It was found that in all the patients the half-turnover rate of
microcirculation (MHR) was higher and the half-turnover time of
microcirculation (MHT) was shorter than normal controls. Vascular
compliance was decreased in all the patients. The mechanism and
significance of the changes in hemodynamics and hemorrheology were
discussed.
Application of a urea kinetic model to hemodialysis schedule. S.H.
Yang, P. Liu, et a!, Nephrology Center, Beijing Medical University,
Bejjing, China. It is important to establish a proper hemodialysis
session length and schedule for a patient on MHD. Thirty patients (20
males, 10 females) on MHD were investigated, aged 30 to 65 (mean,
48,3 10.9), with hemodialysis for 5 to 79 month (mean 25.4 16.4) at
a blood flow rate of 150 to 250 mI/mm. The optimal dialysis schedule
was determined by the optimal dialysis session length (T, mm) and the
length of interdialysis interval (0, mm). The optimal dialysis session
length (hr) was calculated by the formulas (D method): with Kr> 0.3
mI/mm, T = 14* (W — lOKr)/B; with Kr <0.5 mI/mm, T = 14 W/B, B
is blood flow rate (mi/mm). Kr = Vu/Td* urine urea nitrogen/(BUN
post-HD + BUN next pre-HD)/2. If Kr < 0.5 mI/mm, the residual
kidney function is negligible. If T calculated T administered, dialysis
is adequate. If T calculated >T administered, dialysis is inadequate. We
also calculated KT/V by formula (BUN pre-HD — BUN post-HD)/
BUN mid HD (B method). Adequate value was 1.01 0.21; and
inadequate <0.80. By D and B methods, adequate cases were 14/30
(46.7%) and 22/30 (73.2%). The results of D and B method were
compared with the clinical manifestations of dialytic adequacy, the
coincidence rate was 86.7% (P> 0.05) and 53.5% (P < 0.05). Based on
D method, we calculated 6 by formulas derived from single-pool urea
kinetic model: with K = 0.5 ml/min,
0 = [ln(e -KT/V — G/KrC) — ln(l — G/KrC)1;
with K 0.5 ml/min, 0 = (1 — e_l(T/%')VC/G. K was determined by blood
flow rate, V is 60% of the dry weight, G is the urea nitrogen generation
rate, G = [(BUN next pre-HD — BUN post-HD) V + urine urea
nitrogen concentration . V,j/Td. The mean value of 6 calculated was
77.1 19.0 hrs, and Td administered was 76.9 18.4 hrs (P> 0.05) in
20 patients with Kr, while 66.6 13.5 hrs, and 67.0 13.9 hrs (P>
0.05) in 10 patients without Kr. The results showed no significant
difference between 0 and Td (P> 0.05). Our conclusions were: (1) D
method is practical in clinical work and individualized as well; (2) The
calculation of 6 formulas is coincident with the dialytic frequency/week
in clinical dialysis schedule. Thus, the 6 formulas provide a sound
theoretical basis for the dialysis schedule, thus the optimal dialysis
schedule can be determined in terms of D method and 6 formulas.
Comparative study of low dialysate flow rate in hemodialysis. Y. Cheng
and R.X. Zhang, 83 Hospital, Shanghai, China. In order to determine
whether the dialysate flow rate can be reduced in chronic renal failure
patients without adverse effects, a comparative study was undertaken
with a dialysate flow rate of 300 mI/mm or 500 ml/min in 18 patients.
According to a cross-over design principle, each group consists of 9
patients. They were dialyzed for three months at a dialysate flow rate of
500 ml/min and for the other three months at 300 mlfmin. No significant
difference (P> 0.05) was found in the urea and creatinine clearances of
the two flow rates. The same was true for both the urea and creatinine
decreasing rate. Low dialysate hemodialysis (LDHD) had the same
improving effect on biochemical values (hemoglobin, cholesterol, uric
acid, potassium, calcium, phosphate). In addition, the total cost per
dialysis in the LDHD was saved substantially by 13.2% in our unit. In
summary, we found that low dialysate hemodialysis is an effective, safe
and economic way of dialysis.
Clinical evaluation of high-efficiency hemodialysis. M. Liang, X.
Zhang, F.F. Hou, and Y.D. Ling, Department of Nephrology, Nanfang
Hospital, Guangzhou, China. A prospective study of high-efficiency
hemodialysis (HED) was carried out to evaluate the adequacy of this
treatment and the effect on cardiovascular stability and blood B2m
level. Ten patients on maintained hemodialysis were enrolled in this
study. Having been treated with standard hemodialysis (SD) (QB 200
mllmin, QD 500 ml/min, Gambro HF 90, 4 hr x 3/w) for 6 weeks as a
self-control, they were transferred to HED (QB 300 mI/mm, QD 600
ml/min, Baxter CA 170, 3 hr x 3/w) for 4 weeks. TACurea and Kt/V
were used as an index of the level of dialysis therapy; serum B2m,
arterial blood gas analysis and ultrasonocardiography were determined
pre- and post- SD and HED. No differences were found in Kt/V and
TACurea between SK and HED (Kt/V 1.36 0.26 vs. 1.25 0.24 NS;
TACurea 43.8 8.34 mg/dl vs. 43.8 12.9 mg/dl NS). HED could
correct metabolic acidosis as effectively as SD, and there were no
differences in PH, HCO3 and PaCO2 between SD and HED (P> 0.05).
The parameters of cardiac function such as PEP/LVET, mvcf, D%, SV,
CD, Ef%, Ve/Ao and CI had no significant changes after HED when
compared to pre-HED, and the delta of above parameters between SD
and HED also had no statistical significance. Serum B2m levels re-
mained at the same level after HED (65.2 22.6 g/ml vs. 87 28
jg/m1 NS); while in SD it was significantly higher than that in pre-SD
(125.3 47.3 sg/ml vs. 173.4 35.7 g/ml P < 0.001). Based on the
results of our study, we suggest that HED be used as an alternative
method for maintained hemodialysis patients.
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Reversibility of lupus nephritis in dialysis. Y.L. Ji, R.G. Ye, H.O. Li,
et a!, Kidney Research Institute, Sun Yet-Sen University of Medical
Sciences, Guangzhou, China. Patients with end-stage renal failure due
to lupus nephritis may regain sufficient function to discontinue dialysis
after treatment. This paper reports 25 cases on peritoneal dialysis,
which were treated with prednisone and CTX from 198! to 1991.
Twenty-four cases discontinued dialysis for 44.5 25.2 months, and
the Scr was 168—78.7 jsmol/liter six months later. It is suggested that
high dose prednisone and adjunctive cyclophosphamide is indicated for
the following patients with: (1) rapid progression of renal failure; (2)
serious disease activity; and (3) the renal biopsy showing active lesions
with a low to moderate chronicity index.
Acetate-free biofilatration (AFBF): A high efficiency bicarbonate dial-
ysis (BD). Y.J. Wu and J.Y. Lu, Department of Nephrology, First Air
Force Hospital, Shanghai, China. Six patients previously hemodia-
lyzed with KFIO1 dialyzer (Eva! 1.3 m2; 3 5 hr/week; 1—26 months)
were treated with acetate-free bioflltration 3 3 hr/week. In this AFBF
scheme, we used an F60 dialyzer (polysulfane, 1.25 m2) and dialysate
containing (mmol/Iiter; Na 139, K 2, Ca 1.75, Mg 0.41, Cl 145.5). During
each session 4 to 5 liters of a solution containing 179 mmol/liter of
sodium bicarbonate were reinfused at an average speed of 20.6 1 .4
mI/mm in post dilution. All other parameters were kept constant.
Clinical and biochemistry examinations were made during each session.
The results showed: (1) Higher clearance of plasma creatinine, urea,
uric acid and phosphate.
Clearance (m1/mm) during HD and AFBF
Uric
Creatinine Urea acid Phosphate
HD 101.37
23.44
150.0!
21.07
116.95
31.33
132.96
28.06
AFBF 157.67
31.40
180.24
22.23
158.99
28.12
143.36
35.10
In spite of a 2 hour reduction in each session compared with HD, the
removal of plasma creatinine, urea, uric acid and phosphate was not
significantly different between HD and AFBF (49.2% vs. 5 1.2%, 59.2%
vs. 58%, 50.6% vs. 51.3%, 44.3% vs. 46.1%, respectively, P > 0.05).
However, the elimination of B2-microglobulin in AFBF is higher than in
HD (29.08 8% vs. 15.59 5.8%, P < 0.01). (2) Amelioration of acid-base
status and disappearance of intradialytic hepoxemia. (3) Excellent
intradialytic tolerance and significant improvement of appetite and
general conditions. Combining the advantages of hemodiafiltration and
bicarbonate dialysis, AFBF is a time saving, highly efficient, simple,
safe alternative, with few side effects, to bicarbonate dialysis.
Prevention of hepatitis B in patients with maintenance hemodialysis and
renal transplantation. G. Y. Wang, SE. Wang, C. Y. Shi, et a!, Division
of Nephrology and Laboratory of Clinical Virus, Rui-Jin Hospital,
Shanghai Second Medical University, Shanghai, China. Twenty-five
hepatitis-free patients (HD 18, transplantation 7) were randomly di-
vided into control and vaccination groups. The HBIC plus HB vaccine
(40 g) was given intramuscularly at month 0, and the HB vaccine (40
sg) was given at I and 2 months, respectively. In the control group, the
y-globulin plus placebo (inosine 100 mg) was given intramuscularly at
month 0 and the placebo was given at months 1 and 2. Liver function
and HBV test were followed up for 1 year. Results: The incidence of
hepatitis was 8.3% (1 case) in the vaccine group, and 37.7% (5 cases) in
the control group. Among 7 transplantation patients (2 in the vaccina-
tion group, 5 in the control group), I got HB and 1 got non-A, non-B
hepatitis. The incidence of HB was 23%, non-A non-B hepatitis was
15.3% and hepatitis was totally 37.7% within 1 year. In the vaccination
group, the incidence of hepatitis was only 8.3%. In conclusion, the high
incidence of hepatitis B was related to repeated transfusion, use of
dialyzer and low immune function in uremic patients. For the preven-
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tion of hepatitis B in patients with HD and transplantation, general
measures should be taken.
The level of endotoxic antibody in hemodialysis patients. M. Yang,
F.F. Hou, X. Zhang, Department of Nephrology, Nanfang Hospital.
Guangzhou, China. Endotoxins are often present in dialysate. They are
derived from gram-negative bacteria, especially Pseudomonas, E. coli
and Serratia. It has been thought that they can pass through dialyzer
membranes. To investigate this, serum endotoxin antibody level was
measured by ELISA in maintenance hemodialysis patients. The results
showed that the serum level of endotoxin antibody in dialysis patients
was significantly higher than that in non-dialysis CRF patients and
normal controls (P < 0.001). In the first three months of dialysis, a
distinct increase in serum endotoxin antibody level was noted, which
was positively correlated with the time of dialysis (r = 0.254). The
serum endotoxin antibody level was significantly higher in patients
using cuprophan membrane dialyzer when compared with those using
cellulose acetate membrane dialyzer (P < 0.05).
Therapeutic effect of rHuEpo on oxidative injury of red blood cells in
hemodialysis patients with anemia. P. Liu, F.J. Wang, et a!, I.M. Feng,
et al, Nephrology Center, Being Medical University and Biochemistry
Department, PUMC Hospital, Beijing, China. This paper investigates
the oxidative injury of RBC from HD (hemodialysis) patients with
severe anemia and the therapeutic effect of rHuEpo on the oxidative
metabolism of RBC. Twenty-eight patients (20 males, 8 females) on HD
with severe anemia were investigated. The range of age was from 33 to
68 years (mean 50.30 10.90). They had been on MHD for 3 months to
8 years (mean 2.19 1.92). CRF were caused by CGN (21 cases), CPN
(3 cases), arteriosclerotic nephropathy (3 cases), and diabetic nephrop-
athy (1 case). Bone marrow was normal in all patients and had no
evidence of hemolysis or blood loss other than that related to the
dialyzer. All patients had no evidence of iron, VitB12, and folic acid
defficiency. Patients were not receiving androgens or immunosuppres-
sive drugs. We have studied levels of Hb, MDA, 02, reduced glutathi-
one (GSH), enzymatic activity of superoxidase dismutase (SOD),
catalystase (CAT), and glutathione peroxidase (GSH-PX) of RBC in all
patients and in 37 healthy subjects (control group). All these parameters
were measured before and after 6 weeks rHuEpo treatment. rHuEpo
(Amgen products, California, USA) 100 lU/kg was given intravenously
after each dialysis treatment. Results are shown as follows.
Control
rHuEpo treatment
P Value
(Pre
vs.
Post-)Pre- Post-
Hb (g/dl) 142.6 19.8 60.3 18.2 102.0 6.2 0.01
MDA 9.1 3.29 14.66 5.25 9.91 2.42 0.001
(nmol/
gHb)
°2 (zmol/ 0.44 0.23 2.43 1.90 1.07 0.51 0.005
gHb/4
hr)
SOD (g/ 1901.4 872.9 2596.88 1221.9 1996.4 695 0.02
gHb)
CAT (IU! 31.42 6.67 36.69 6.677 27.98 10.6 0.001
gHb)
GSH 7.00 1.56 7.00 1.288 8.10 1.89 0.5
(mol/
gHb)
GSH-PX 17.9 6.46 15.92 4.23 19.14 6.23 0.2
(U/gHb)
These data suggest that SOD and CAT should play an important role in
the elimination of the oxidative metabolites in RBC.
The effect of hemodialysis on deformability of red blood cells in patients
with uremia. Z.Z. Zhou, S.F. Wang, J.J. Li, J. Du, L.X. Zhang, and T.
Lu, Department of Nephrology, Department of Hematology, 304th
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Filtration index =
Filtration time of normal saline
Filtration time of RBC
x 100
Our results showed that RCD in pre-dialysis blood of uremic patients
was significantly lower than that of healthy volunteers (P < 0.002).
Post-dialysis RCD of uremic patients was also lower than that of
healthy volunteers, but it rose by 48.21% against pre-dialysis RCD. The
post-dialysis RCD was increased in all 5 patients dialyzed by dialyzers
that had been used less than five times, whereas it slightly decreased in
4 of 5 patients with dialyzers used over five times. The decrease in REC
was correlated with the times of use of the dialyzer. There results
suggested that RCD in uremic patients was lower than that of healthy
volunteers, and hemodialysis could efficiently increase it, which indi-
cated that some toxic substances not effectively excreted by the kidney
had impaired the deformability and flexibility of red blood cells. The
repeated use of the dialyzer would cause a decrease in its ability to clear
toxic substances. Our experience indicated that the dialyzer should not
be repeatedly used more than five times.
Effects of the plasma in patients with chronic renal failure before and
after dialysis on erythrold progenitor cells and the assay of erythropoietin.
H.B. Wang, J.M. Chen, Z. Y. Zhang, et al, Department of Internal
Medicine, the Second Affiliated Hospital of Hubei Medical University,
Wuhan, China. The pathogenesis of anemia in patients with chronic
renal failure (CRF) was studied in assaying the growth of erythroid
progenetor cells (CFU-E and BFU-E) in vitro, the concentration of
serum erythropoietin (EPO), folic acid (FA), VitB 12 and serum ferritin
(SF), and abnormal erythrocyte of peripheral blood smear. After the
mixed plasma of uremic patients of nondialysis, continuous ambulatory
peritoneal dialysis (CAPD) and hemodialysis (HD) was separately
cultured with the erythroid progenitor cells of bone marrow of twenty-
two patients with CRF of nondialysis and of twenty-two normal
persons, it was found that the erythroid progenitor cells of bone marrow
of nondialysis patients with CRF was not different from the normal
control without uremic environment (P > 0.05). The mixed plasma of
patients with CRF of nondialysis, CAPD and HD could inhibit the
growth of the erythroid progenitor cells. The growth of BFU-E was
even more inhibited than that of CFU-E. In addition to inhibition of
erythropoiesis, the concentration of serum EPO of nondialysis patients
with CRF was obviously reduced as compared to normal controls. In
conclusion, there are inhibitors of erythropoiesis in blood of patients
with CRF, which may include high, middle and small molecular
substances. The inhibition of growth of the erythroid progenitor cells
and EPO deficiency may be the major cause of anemia in patients with
CRF. The deficiency of FA and iron, and the hemolysis may aggravate
anemia.
Elevated erythrocyte aluminum (EAL) inhibits hemoglobin synthesis
(HBS), but not erythropoiesis in hemodialysis patients (HDP). D.X. Lou,
J. Zhao, X.O. Dong, et al, Department of Nephrology, Riu-Jin Hospi-
tal, Shanghai Second Medical University, Shanghai, China. Al over-
load in dialysis patients is associated with the development of anemia.
The mechanism of Al toxicity in erythrocytes is not clear. EAI, serum
Al (SAl) and bone Al (BAI) in HDP were measured to evaluate the
effects of Al in tissues on erythrocyte production and HBS. EAI (119.9
46.85 pg/liter, N = 22 vs. 44 11.4, in normal, N = 21, P < 0.001)
was elevated and showed a positive correlation with SAl (r 0.6536, P
<0.025). EM had an inverse correlation with Hb (r =
—0.4968, P <
0.025), but not with RBC count and Ht. SAl had no correlation with Hb,
RBC and Ht. Al levels in various tissues and relations between them
and BAI were as follows:
Effect of parathyroid hormone (PTH) on erythropoiesis in vitro and in
hemodialysis patients (HDP). J. Zhao, D.X. Lou, H.D. Chao, et al,
Department of Nephroiogy, Rui-Jin Hospital, Shanghai Second Med-
ical University, Shanghai, China. Whether PTH plays a role in the
cause of anemia in CRF by suppression of erythropoiesis remains
controversial. In this study, we observed the action of intact PTH and
N-PTH (1—34, Sigma Co.) on the human erythroid progenitor cells
(CFU-E, BFU-E) and studied the correlations between plasma C-PTH
(53—84, RIA, ORIS Co.) and hematocrits (Ht), and the RBC count in
HDP. The data are shown below:
CFU-E P BFU-E P
Control 621 16 30 7
Int. PTH 175 38 <0.001 21 9 >0.05
1000 pg/mi
N-PTH 311 <0.001 18 7 <0.05
10,000 pg/mI
a compared to the control
The dose-dependent inhibitions of CFU-E and BFU-E colony growths
were found in the intact PTH and N-PTH, except for the intact PTH to
BFU-E. An inverse correlation of PTH with Ht (r = 0.3848, P < 0.05)
and RBC count (r =
—0.3877, P < 0.05), but not with Hb was presented
in HDP. Our conclusions were: (1) PTH shows greater inhibition to
CFU-E than to BFU-E. (2) The activity of inhibition may reside in
N-PTH. (3) PTH probably suppresses the production of erythrocytes
other than synthesis of Hb in HDP.
Different influences of hemodialysis and peritoneal dialysis on bone
marrow hemopoietic progenitor in patients with uremia. L.M. Li, Y.J.
Zhou, X.J. Wang, et al, S.L. Qi, J. Fu, Air Force Tianjin Hospital,
Tianjin, and Institute of Hematology, CAMS, Being, China. More
than 95% of patients with uremia also have anemia. To evaluate the
potential role of dialysis in bone marrow hemopoietic progenitor in
patients with uremia, bone marrow hemopoietic progenitor cultures of
32 cases of uremia were done. The study consisted of 21 males and 11
females, aged 19 to 68 years, and the course of uremia was 2 to 36
months. There were 10 cases in the nondialysis group, 10 in the
pei-itoneal dialysis group, and 12 in the hemodialysis group; a control
group of 12 was selected. The results were as follows: The colony
numbers of CFU-E were 86.9 71.4, 216.7 154.0, 33.1 27.9, and
135 5.0, respectively. There was a significant difference between the
peritoneal dialysis group and the hemodialysis group (P < 0.01). The
colony numbers of CFU-F were 71.5 43.2, 151.4 92.8, 55.8 43.4,
and 146.6 30.1, respectively. There was also a significant difference
between the peritoneal dialysis group and the hemodialysis group (P <
0.01). The results showed that the CFU-E and CFU-F were obviously
inhibited in patients with uremia. They also indicated that the erythro-
poietic inhibitors in uremia plasma have effects not only on hemopoietic
progenitor, but also on bone marrow microenvironment, Colonies of
CFR-E and CFR-F were obviously increased after peritoneal dialysis.
While they were not improved in the group of hemodialysis, it is
because of the higher clearance rate to erythropoietic inhibitors of
peritoneal dialysis than that of hemodialysis.
Hospital, Beijing, China. The change in deformability of red blood cells
before and after hemodialysis in uremic patients was investigated. The
observation was made in 62 healthy volunteers (30 males, aged 23—57
years, 32 females, aged 20—57 years) and uremic patients (7 males,
30—60 years in age, 3 females, 28—68 years of age). The RCD was
measured with a type CQ-2 apparatus. A blood sample was obtained
only once from healthy volunteers, whereas in uremic patients, samples
were collected before and after hemodialysis. RCD was represented by
filtration index, which could be expressed by the following formula:
N X±SD P r
BAt mg/kg d 8 37.67 54.11 <0.01
EAI p.g/iiter 22 119.9 46.85 <0.05 0.2239 NS
SAl pg/liter 20 93 36.3 <0.001 —0.224 NS
Hb g/liter 22 64.1 15 0. 1072 NS
RBC 10'Vmm3 22 209.45 38.62 0.5 NS
Controls: BA1, 3.83 2.65; SAl, 10.68 6.05; EAt, 44 11.41
Pa: as compared to controls; NS, no significance; d, dry.
x hematocrit In conclusion, the EAI assay is probably more accurate than the SAl
assay in reflecting Al toxicity on erythrocytes. EAI overload may inhibit
HBS other than erythrocyte production.
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Intermittent whole-day peritoneal dialysis (IWPD) in treating chronic
renal failure. W.D. Qiu, S.C. Tong, Y. Yu, HO. Li, and S.M. Li,
Kidney Research Institute, Sun Yat -Sen University of Medical Sci-
ences, Guangzhou, China. An intermittent whole-day peritoneal dialy-
sis (IWPD) has been developed, that is, a total capacity of dialysate
used in a week in continuous ambulatory peritoneal dialysis (CAPD) is
divided into two parts. Each part is divided into 10 exchanges. Dialysis
is performed at 8, 10, 12, 14, 16, 18, 20, 22 o'clock and 0, 4 o'clock the
next morning (once every 3 days). Sixteen chronic renal failure cases
were included in this program, and treated for 6 to 36 months. Data
were compared using the unpaired or paired Student's t-test between
the IWPD group and the CAPD group. The results showed: (1) In most
of the patients, the general conditions (body weight, blood pressure,
appetite, urine volume, etc.) were similar to those of CAPD patients. (2)
In small molecular solutes and middle molecules (MM) clearance of
peritoneum, IWPD was better and lost less protein than CAPD (P <
0.001). (3) Blood parameters were kept stable. The levels of serum
potassium, phosphorus, and BUN were slightly lower than those of
CAPD (P < 0.001, 0.05, 0.01, respectively), while serum total protein
(Tp) and complement components (C3, C4) concentrations were in-
creased (P < 0.05). The serum calcium levels of seven patients were
increased slightly after 2 years. Serum aluminum levels of the IWPD
group, however, were higher than those of the CAPD group (222.50
126.20 vs. 111.25 73.60 pg/liter, P < 0.05). Plasma PTH levels, in
both CAPD and IWPD groups, were much higher than the control,
while there was no significant difference between the CAPD and IWPD
groups. (4) Because the connecting and disconnecting tubes were
reduced from 20 to 2 times a week, and patients' serum Tp, immuno-
globulin, C3, and C4 levels increased, only 3 episodes of peritonitis
occurred in 257 patient months, an incidence of 1/85.67 patient months.
(5) Renal bone disease was not improved as in patients with CAPD. (6)
The elevation of B2-microglobulin in IWPD patients was the same as in
the CAPD patients (52.97 8.83vs. 53.64 4.43 mg/liter, P> 0.5). No
dialysis-associated amyloidosis was discovered in either group.
Continuous ambulatory peritoneal dialysis (CAPD) in older patients at
home. D.X. Ji and L.S. Li, Jinling Hospital, Nanjing, China. CAPD
was performed on 184 patients from November 1980 to March 1991.
Among them, 34 patients, 22 males, were over age 60 (the aged group),
and the results were compared with those in 150 non-aged patients.
There were more diabetic, hypertension and cardiac insufficiency cases
in the aged. There was no significant difference between other clinical
and biochemical parameters before CAPD. The results showed that: (1)
Hb, albumin, pre-albumin and transferrin were lower in the aged than
the non-aged. There were no significant differences in BUN, 5cr'
calcium, phosphate and B2-m. (2) The incidence of peritonitis was 1/8.3
months in the aged and 1/15 months in the non-aged people. The main
cause of peritonitis was the infection of canal and the skin exit. (3) The
major cause of death was cardiac and cerebral vascular complications in
the aged people and peritonitis in the non-aged. The mortality in old
patients on CAPD was lower than those on hemodialysis. It can be
concluded that: (I) In old patients with end-stage renal failure, CAPD is
the first choice of therapeutic regime. (2) Cardiac and cerebral vascular
complications are the main causes of death in older patients on CAPD.
(3) Sufficient nutrition is very important for older patients.
Prevention and treatment of bacterial peritonitis in peritoneal dialysis
for 18 years. R.G. Ye, S.f. Chen and X.P. Li, Kidney Research
Institute, Sun Yan-Sen University of Medical Sciences, Guangzhou,
China. 357 patients treated with peritoneal dialysis from 1973 to 1990
(2,250 patient months) were studied. Bacterial peritonitis was diagnosed
by 2 or more of the following features: (1) Symptoms and signs for
peritonitis. (2) Turbid dialysate with increased leukocyte counts (0.1 x
109/liter), and neutrophils 50%. (3) Bacteria seen on gram stain in
sediment or on dialysate culture. The results were: (1) 118 of 357
patients had bacterial peritonitis (157 episodes). There was no signifi-
cant difference of the incidence (patient month/episode) of bacterial
peritonitis between males and females, 50 years and 50 years old, and
uremia caused by chronic glomerulonephritis and other diseases (13.9
vs. 14.7, 15.02 3.24 vs. 13.58 1.72, 14.57 1.54 vs. 14.58 1.49,
F> 0.05). (2) The main clinical features were: abdominal pain (95%),
abdominal tenderness (80%), rebound tenderness (29%), abdominal
distention (70%), fever (40%), chills (6.4%), no symptoms and signs
(1.6%); dialysate change: Turbid dialysate (99%), leukocyte counts 0.5
l09/liter (75.2%), neutrophils 50% (95.8%); dialysate bacterial culture:
64.5% positive in routine method and 83.5 positive in dip-slide, with
significant differences (P < 0.01);organisms: 64.5% were gram-positive
organisms, among which staphylococcus epidermidis was most com-
mon; 37.5% gram-negative, in which colibacillus was the most com-
mon; the first episode of peritonitis occurred in 150.9 23.3 days after
the dialysis; by efficient treatment, peritonitis could be controlled in
3.42 1.75 days. (3) Occurrence of peritonitis is related to techniques
of peritoneal dialysis. Using a Tenckhoff catheter, B style connector
was handled by well trained nurses, and the incidence of peritonitis was
significantly decreased from 2.1 patient months! episode to 12.3 patient
months/episode and now 18 patient months/episode. (4) After treat-
ment, 75.8% patients with peritonitis underwent peritoneal dialysis
continuously, 20.6% switched to the hemodialysis, and 2.5 stopped
dialysis because their uremia was cured and 1% died (most died from
heart failure and infectious shock).
Evaluation on the partial omental excision in the prevention or the
obstruction of peritoneal catheter. F.H. Yuan and L.S. Liao, Depart-
ment of Nephrology, Xinqiao Hospital, Chongqing, China. To prevent
omentum induced obstruction of Tenckhoff catheters, 36 chronic renal
failure patients with peritoneal dialysis were divided into two groups.
When planting catheters, partial omental excision was performed in
group 1(8 males and 10 females) and no omental excision in group 11(8
males and 10 females). During 75.4 dialysis months in group I, 1 case
had catheter obstruction caused by the fibrin, and 11 had bloody
outflow for 1 to 3 days after the operation, with a peritoneal creatinine
clearance of 18.5 2.1 ml!40 mm/kg body wt. In group II for 55.0
dialysis months, 7 cases (P < 0.05) had catheter obstruction (5 caused
by the omentum getting into the holes of the catheter, 1 by the fibrin),
and none had bloody outflow (P < 0.05), with a peritoneal creatinine
clearance of 19.1 3.5 (P < 0.05). It is concluded that partial omental
excision could effectively prevent the obstruction of catheters without
affecting the peritoneal creatinine clearance, but usually caused bloody
outflow. Therefore, one must be careful in performing this operation.
Isolation and purification of high molecular weight materials (11MM)
from CAPD dialysate outlet and their inhibitory effects on mouse bone
marrow progenitor cells and lymphocytes in vitro. C.L. Yang, X.H. Du,
and H. Wu, China-Japan Friendship Hospital, BeUing, China. Isolation
and purification of HMM from CAPD dialysate outlet of 2 ESRD
patients were carried out by precipitation, desalting, gradient elution,
chromatography and concentration. SDS-PAGE was used to measure
the molecular weight (MW). The aim of this project was to investigate
whether HMM could inhibit erythropoiesis and lymphocyte transfor-
mation (LT) in vitro. Tris Buffer 0.1 ml, uremic serum 0.2 ml, 0.1 ml of
HMM 23—64 KD isolated from the CAPD dialysate outlet of patient A
(F Al) and B (F Bl), and 0.2 ml of HMM 67 KD from patient A (F A2)
were separately added and cultured with mouse bone cells. Then,
CFU-E, BFU-E, CFU-C and LT were measured. We found that the
uremic serum, F Al and F Bl could inhibit CFU-E and BFU-E very
significantly (P < 0.001) but not CFU-C. Uremic serum, and F Al could
inhibit LT significantly (P < 0.01), while FA2 could inhibit neither
CFU-E nor BFU-E. If the dosage of EPO enlarged by 3 to 6 times, F Al
could not express its inhibitory effect on CFU-E or BFU-E. Our data
suggested that: (1) The HMM of 23—64 KD isolated from the CAPD
dialysate outlet of ESRD patients could inhibit erythropoiesis and
suppress cellular immunity in vitro. (2) These HMM could be removed
from uremic serum by CAPD, which may play a role in the improve-
ment of uremic anemia and immunity. (3) Increase of EPO dosage could
overcome the inhibitory effect of these HMM on bone marrow progen-
itor cells and LT in vitro.
Prognostic importance of bicarbonate diuresis in patients with chronic
hypercapnia. N.M. Chen, D.P. Yin and M.L. Feng, Department of
Internal Medicine, the Affiliated Hospital, Nanjing Railway Medical
College, Nanjing, China. Factors that mediate the renal responses to
hypercapnia are elusive. Schwartz (1965) found that in chronic hyper-
capnia, there was an increase in bicarbonate excretion besides acid
excretion. Madias (1985) also showed that following the elevated
ammonium excretion, bicarbonate excretion increased to a significant
degree as well in HCI-fed dogs after prolonged exposure to high CO2
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tension. Since a normal person tolerates prolonged exposure to high
CO2 poorly, renal response to chronic hypercapnia has not been
observed in humans, The present study was designed to evaluate the
effect of hypercapnia of bicarbonate excretion in humans. Eighteen
COPD patients, aged 55 to 76 years, complicated by chronic hypercap-
nia (that is, hypercapnia persisting beyond the 5th day) were investi-
gated. Eight age-matched normal persons were used as controls.
Patients' urine was collected under paraffin oil and tested for pH, PCO2,
Na, K, Cl, Cr, NH4 and TA. The patients blood was tested for pH,
PCO2, P02, Na, K, CI and Cr synchronously. During chronic hyper-
capnia, excretion of bicarbonate was more increased than that of the
acute hypercapnia and normal subjects (P < 0.001). Patients' urine was
alkaline with pH 6.75 0.37 in this period. Bicarbonate diuresis,
besides acid excretion, is of prognostic importance in patients with
chronic hypercapnia when renal adaptation reaches a relatively steady
state. This serves as a defense mechanism,
Experimental nephrology
Comparative study of immunosuppressive effect of T2, T4 CsA and
MP. X.W. Li, Y.F. Pu, L. Duan, et al, Division of Nephrology,
Department of Medicine, Peking Union Medical College Hospital,
Beijing, China. Previously, we confirmed the Chinese herbal medicine
Trypterigium wilforclii (TW) was an effective immunosuppressive drug.
In this study, we compared the immunosuppressive effect between the
two different TW: T2 (a complex material) and T4 (a pure material); T2
and cyclosporine (CSA); T4 and methylprednisolone (MP) in the in
vitro and in vivo study. The concentration of T2 used in the in vitro
study was 2.4, 1.2, 0.6 and 0.3 j.gIml, respectively; and that ofT4 10, 5,
2.5, and 0.625 ng/ml, respectively. No direct cytotoxicity to PBMC of
both TW at the concentration was found, Both T2 and T4 inhibited the
PBMC transformation in Vitro stimulated by Con A or PHA. The half
inhibition concentration was 5 ng/ml in T4 and 2.4 pg/mI in T2. The
percent of inhibition from combined use of T2 (0.6 pg/mI) and C5A (150
nglml) was more than CsA 600 ng/ml (74.23% vs. 73.01%). T2 CsA and
MP were confirmed to be effective in the inhibition of mice DTH and the
inhibition of T2 30 mg/km/d was equal to CsA 25 mg/km/d, or MP 12.5
mg/km/d. T4 inhibited the cultured human embryo glomeruli mesangial
cell, and the proliferation in fashion of time and dosage dependent, but
MP showed no inhibition. We conclude that both T2 and T4 signifi-
cantly inhibit PBMC transformation; T2 has some additional immuno-
suppressive effect on CsA and can significantly inhibit the mice DTH.
T4 inhibits the cultured human embryo glomeruli mesangial cell prolif-
eration.
Effects of ganoderma capense (GC) on membranous glomerulonephritis
(MGN) of rabbits in experimental study. YR. Ma, L.J. Lu, Z.Q. Wang,
et a!, Department of Pathology, Luzhou Medical College, Sichuan,
China. In this study the therapeutic effects of traditional Chinese
medicine (GC) on MGN models of rabbits, [slightly modified Border's
model-models of immune complex in situ (P)] were observed and
compared with 4 other groups, namely, the normal control group (N),
the OC group (T1), Western medicine group (cyclophosphamide and
dexamethasone, T2) and the combination of T and T2 group (T3).
Twenty-six male purebred Japanese big-ear-white rabbits were chosen
and separated randomly into 5 groups, The observation indicated that
compared to the results in the 5th week before and 12th after treatment,
in each group (except N and P group), the intensity of 3 immunofluo-
rescences was weakened obviously after treatment (+ + +—+ + + + to
Besides, observed qualitatively in LM and quantitatively in
EM, the swelling glomeruli became smaller (average diameter de-
creased from 70.31 2.36 m to 48.68 2.21 sm), and the average
diameter of the subepithelial electron dense deposits was reduced from
928.81 25.53 nm to 764.32 36.57 nm and absolute numbers of 3.63
IO were also reduced to 1.12 l0; the thickness of GBM was decreased
from 369.57 24.46 nm to 182.13 9.48 nm and the window holes of
endotheliocyte did not change obviously before and after treatment
(101.33 14.33 nm to 103.68 7.78 nm). The qualitation of proteinuria
dropped gradually (+ + +—+ + + + to and the excreta of pro-
teinuria in 24 hours lowered remarkably (0.32 0.05 g/liter to 0.014
0.008 g/liter). The plasma albumin rose from 28.70 1.20 g/liter to 36.50
3.43g/liter and the plasma globubin, creatinine, cholesterol and BUN
varied slightly before and after treatment. Compared to the above-
mentioned indices and parameters after and before treatment, most of
them were remarkably different (P <0.05-P < 0.001).Moreover, in the
renal function and the thickness of GBM, the therapeutic effects in T,
group were better than T2, and the T3 group was the best among the 3
groups. This investigation shows that the therapeutic effects of tradi-
tional Chinese medicine (GC) on MGN of rabbits are quite obvious and
the combination of GC and cyclophosphamide and dexamethasone is
more effective.
Rheum ofilcinal inhibits hyperfiltration induced by L-arginine In rats.
L.O. Chen, S. Y. Lin, Y.M. Gu, et a!, Huashan Hospital, Shanghai
Medical University, Shanghai, China. The Chinese herb rheum officinal
(OR) is reported to reduce the rate of decline of renal function in
patients with end-stage renal disease. To investigate if the beneficial
effect is related to its influence on hemodynamic changes, which is
believed to be one of the factors causing progressive decline of renal
function, the effect of OR on L-arginine induced hyperfiltration and
hyperperfusion was observed. Male SD rats were anesthetized with
sodium pentobarbital. Femoral artery, femoral vein and bladder were
catheterized for blood sampling, infusion and urine collection, respec-
tively. After a period of equilibrium, 3% OR (OR group, N = 10) or
0.9% NaCI (control, N = 10) was infused (2 ml/hr). One hour later,
6.25% L-arginine was infused (2 mI/br) with OR or 0.9% NaCI. Urine
and blood were collected every 30 minutes throughout the experiment.
Inulin and PAH were determined; GFR and RPF were calculated. In the
control group, GFR increased from 0.62 0.07 to 1.18 0.14
ml/min/100 g (P < 0.05), RPF from 2.88 0.43 to 6.32 1.41
ml/min/100 g (P < 0.05) after arginine infusion. In the OR group, GFR
did not change significantly after arginine (0.74 0.07 vs. 0.78 0.11
inl/min/100 g; P> 0.05), but RPF still increased after arginine infusion
(from 3.57 0.76 to 4.89 1.12 ml/min/lOO g; P < 0.05). Before
arginine infusion, GFR and RPF were similar between the two groups
whether or not OR was added. We conclude that OR could inhibit
L-arginine-induced hyperfiltration.
Experimental study of rheum ofilcinale to delay the progression of
chronic renal failure (CRF). J. W. Yang and L.S. Li, Jinling Hospital,
Nanjing, China. Rheum officinale (RO), a Chinese herbal drug, is
known to be able to delay the progression of CRF. To investigate the
mechanism of RO, 5/6 nephrectomized (Nx) male rats were treated with
RO and Enalapril (EN) for 4 weeks 3 months after nephrectomy. The
RO group, with the Nx group, showed lower levels of serum creatine
(Scr), urea nitrogen (BUN), triglycerides (TG), cholesterol (CH) and
LDL-Ch. Moreover, RO could diminish the enhanced oxygen con-
sumption (QO2) and compensatory renal hypertrophy (KWIBW) in Nx
rats. Urine protein excretion (UprV) was also decreased in both RO and
EN groups. The results are shown as follows:
Normal
N=9 RON=12 ENN=12 ControlN=1l
KW/BW % 5.21 0.66 6.50 1.03c 7.02 0.7 7.61 0.9la
Q02 2.11 0.57 2.30 087b 3.06 0.74 3.66 o.75
p,mo!/min
Cm 1.37 0.27 0.98 021b 0.94 024" 0.73 o.17
mI/mm
Scr 68.4 21.3 190.0 67.5' 219.3 480b 272.6 56.8a
p.mol/liter
BUN 17.4 2.0 21.9 3.8a 24.2 4,7a 31.7 8.9k
mmol/liter
TG 0.67 0.13 1.51 0.42" 1.62 0.41" 2.06 0.51a
mmol/liter
Ch 2.95 0.61 3.26 0.70" 3.36 0.80" 4.26 O.89a
mmol/liter
UprV
mg/24 hr
10.3 5.4 35.7 13.7C 58.4 203b 120.8 38.3a
P < 0.01 vs. normal, b P < 0.05, C P < 0.01 vs. control
It is concluded that RO is valuable in delaying the progression of CRF.
Effects of rheum officinale (RO) on diabetic nephropathy (DN) in
uninephrectomized rats. .1. W. Yang and L.S. Li, Jinling Hospital,
Nanjing, China. Loss of renal mass in rats with diabetes mellitus leads
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to exaggerated hypertrophy of remaining nephrons and accelerated
diabetic glomerulopathy. To study the effects of RO on compensatory
renal growth, oxygen consumption (Q02), azotemia, glucose (BF) and
lipid metabolism (TG, Ch) were determined in male streptozotocin
induced diabetic rats with uninephrectomy. After 8 weeks of treatment
renal growth was suppressed and it is shown that RO is effective in
diabetic rats. The results are as follows:
Control
N=9 DN ratsN=10 RON=10
KW/BW x3 6.85 0.62 13.5 0.83a 10.4 0.47"
Q02 nmollmin 2.46 0.37 4.37 0.97a 3.10 0.52"
BG mmol/liter 5.96 0.24 22.22 3.04a 17.46 2.66"
Scrp.mol/liter 91.1 10.6 199.8 64.5a 127.5 60.1"
TG mmol/ljter 0.67 0.13 1.87 0.52a 1.53 0.40C
Ch mmol/liter 3.49 0.17 5.14 I.09a 3.91 1.21C
UprotV mg/24 hr 12.6 7.5 142.6 56.4a 80.5 24.4C
a p < 0.05 vs. controls; b P < 0.05; C < 0.01 vs. DN
Effects of rheum officinale (RO) on the proliferation of renal tubular
cells in vitro. F. Zheng and L.S. Li, Jinling Hospital, Nanjing, China.
Rat renal tubules were isolated and grown in culture. The effects of RO
on the proliferation of renal tubular cells were investigated. It was
found that the addition of either the sera obtained from rats fed with RO
or the ingredient of this drug, emodin (at final concentration of 0.5—10
mg/mi), directly to culture, all exerted strongly suppressive effects on
the proliferation of renal tubular cells in a dose dependent manner, as
measured by the uptake of radiolabeled thymidine. This obesrvation
may help to explain the beneficial effects of RO in the treatment of
chronic renal failure.
The roles of Astragali and Angetica (A&A) on the protein metabolism
in nephrotic rats. J. Gu and J.S. Pan, Division of Nephrology, First
Hospital, Beijing Medical University, Beijing, China. We investigated
the roles of A&A and protein intake in correcting the metabolic
disorders of the protein in nephrotic rats by means of the dynamic
method. The rats made nephrotic by injection of puromycin were
divided into four groups: with A&A or without A&A, high-protein-diet
(27.3%), or low-protein-diet (18.1%). The observation period lasted 15
days. The dynamic study with '5N-glycine as a tracer was performed at
the 14th day of the experiment. The hypoalbuminemia in nephrotic rats
could be little improved by either feeding A&A or increasing the protein
intake. The rate of the protein synthesis of the rats fed both on
high-protein-diet and given A&A increased markedly, while the rate of
protein breakdown remained unchanged. Their serum albumin re-
mained in normal range, though the heavy proteinuria still existed. The
results suggested that A&A could be thought to accelerate the protein
synthesis in nephrotic rats as long as the protein supplement was
sufficient.
Albumin mRNA study of hepatic protein synthesis in nephrotic syn-
drome rats treated with Chinese herbs. L.X. Li, H. Y. Wang, S.L. Zhu,
and J,S. Pan, Division of Nephrology, the First Hospital, Beijing
Medical University, Beijing, China. It was found in our previous studies
that Astragali and Angelica (A&A) could raise the level of serum
albumin in nephrotic rats, and A&A with a high protein diet could
markedly increase the rate of protein synthesis in nephrotic rats. Serum
albumin of these rats remained in the normal range, although their
heavy proteinuria still existed. A further experiment was designed to
investigate the roles that A&A and protein intake play in the level of
albumin's mRNA in nephrotic rats. S.D. rats (male) were divided into
three groups: (I) high protein diet (39.7%, HP); (2) HP with nephrotic
syndrome (HPN); and (3) HPN with therapy (HPNT). Experimental
rats were preimmunized by subcutaneous injection of rabbit IgG 5 days
in advance, and injected with rabbit serum anti-renal cortex of rats
through the caudal vein (I ml/200 g body wt), and consequently
developed the nephrotic syndrome. The rats with therapy were fed
daily on A&A liquid for 14 days. The urine was collected every day to
determine the protein loss. At the 15th day, the rats' serum and liver
were collected and the level of albumin serum and mRNA were
measured with dot plot. The level of albumin mRNA in HPN was higher
than HP and lower than HPNT. The results suggested that the level of
albumin mRNA increased in the nephrotic rats fed with high protein
diet, and more increased in the rats fed with high protein diet and A&A.
The modulating effect of Chinese herb medicine on the immunoactivity
of MRL/lpr mice. X.M. Chen and N. Zhu, Department of Nephrology,
General Hospital of Chinese PLA, Beijing, China. Mice carrying the lpr
mutation can develop massive lymphadenopathy and severe autoim-
mune diseases. In this study, the Chinese herb medicine Tripterygium
Wilfordii (TW, 40 mg/kg/day) and Astragalus Propinquns Schichk
(APS, 1.0 g/day) were used to treat the 11-week-old MRL/lpr mice.
After treated for 13 weeks, the mice were killed at the age of 24 weeks,
the titres of IgG, IgA, 1gM antibodies to double-stranded DNA (ds-
DNA) and single-stranded DNA (ssDNA) in the serum were measured
by ELISA. Clq solid phase binding assay was taken to determine the
level of dC. The results showed: (1) TW and AAPS decreased the titer
of the anti-ssDNA antibodies in the MRL/lpr mice. (2) TW reduced the
titer of anti-dsDNA IgA antibody (0.070 0.029 vs. 0.213 0.132, P <
0.05) and APS decreased the levels of anti-dsDNA 1gM antibody (0.157
0.036 vs. 0.355 0.194, P < 0.05) and anti-dsDNA IgA antibody
(0.095 0.045, P < 0.05). (3) APS limited the level of CIC in the serum
of the mice (0.193 0.066 vs. 0.348 0.155, P <0.05). These results
indicate that Chinese herb medicine TW and APS could modulate the
immunoactivity of MRL/lpr mice.
Groups N
Anti-ssDNA antibodies
IgG IgA 1gM
Control 7 1.071 0.104 1.185 0.406 1.222 0.557
TW 6 0.933 0.056 0.711 0.163 0.440 0.189"
APS 7 0.842 0129b 0.653 0156b 0.387 0.201"
Compared with control group: a P < 0.05, b P < 0.01
Effects of tripterygium Wilfordii and Astragalus Propinquns Schichk
on lymphocyte and cytokine in MRL/Ipr mice. X.M. Chen and N. Zhu,
Department of Nephrology, General Hospital of Chinese PLA, Beijing,
China. The MRL/lpr strain of mice is an autoimmune deficiency animal
model. In this study, Chinese herbal medicine Tripterygium Wilfordii
(TW) and Astragalus Propinquns Schichk (APS) were used to treat the
Il-week-old MRL/lpr mice. Thirteen weeks after treatment, the single
cell suspensions from thymus, spleen and lymph node of animals were
prepared and stained with the fluorescein labeled rat-anti-mouse anti-
bodies of Thyl.2, B200, L3t4 and Lyt2, respectively. The positive rate
of lpr mutation cells was counted with a flow cytometry (FACS 440).
The positive rate of lpr cell (%)
Group N Spleen Thymus Lymph node
Control 7 18.4 2.84 30.1 6.85 29.8 4.57
TW 6 14.1 3•99a 18.9 7.18" 25.9 9.11
APS 6 15.2 7.07 17.9 12.9 32.1 2.46
Compared with the control group: a p < b P <0.01
The results showed that TW could inhibit the proliferation of lpr cells of
the thymus and spleen in the MKL/lpr mice, but APS could not. The
production of IL-2, IL-6 from the spleen cells of the mice increased
under the stimulation of APS (IL-2: 0.346 + 0.056 vs. 0.244 + 0.064, P
<0.001; IL-6: 0.319 0.067 vs. 0.238 0.024, P <0.01). TW and APS
lowered the level of TNFa from the spleen cell of MRL/lpr mice (TW:
0.349 0.011 vs. 0.362 0.009, P < 0.05; APS: 0.328 0.018, P <
0.05). These results suggested that TW and APS might have regulatory
effects on the cellular immunity of MRL/lpr mice.
Protective effect of vitamin E and a Chinese herb Lycium Barbarum
Polysaccharide (LBP) on the aging of renal mitochondria. X.M. Li, H. I'.
Wang, J. Han, et al, Division of Nephrology, The First Hospital,
Beijing Medical University, Beijing, China. The purpose of this study is
to investigate further the protective effect of Vitamin E and a Chinese
herb LBP on the aging of renal mitochondria. Young (3 months) and
aged (18 months) Wistar rats were divided into 4 groups: young (Y) and
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aged (A) control groups which were fed with routine diet and drinking
water; LBP and Vit-E aged groups which were fed with routine diet and
drinking water with LBP (4 mg/kg/d) or Vit-E (4 mg/kg/d) being added
from 16-month-old for 2 months. The results are as follows:
Groups
Y
A
LBP
Vit-E
(10)
(10)
(10)
(10)
139.13
120.38
131.74
139.47±
11.65
16.72a
15.40"
1132"
12.86 3.16
30.40 6.66a
22.22 8.84c
15.33 116"
a : A vs. Y: P < 0.01; b: L or V vs. A: P < 0.01; C: V vs. L: P < 0.05
Comparing the electron microscopy features of renal mitochondria in
the proximal tubular cells among four groups, we found that changes of
swollen or malformation in mitochondrial shape were lower in LBP and
Vit-E groups than those in A group. The analysis of morphometry
revealed that the specific surface (S) of mitochondria were 6.12 1.42,
3.94 0.77, 4.56 0.18 and 5.17 in Y, A, LBP and Vit-E groups,
respectively (P < 0,01). But the degenerative changes of mitochondria
were not improved in aged groups with or without medicine. The results
suggest that lipid superoxide lesion of free radicals in biomembrane is
related to renal mitochondria aging. Drugs against free radicals or its
biomembrane damage, such as Vit-E or LBP, may prevent mitochon-
dna from aging and improve their function.
The role of hyperlipemia In the initiation of glomerular injury. W.S.
Yang, J.Z. Li, H. Y. Wang, J. Li, K.H. Han, J.M. Hong, Nephrology
Center, BeUing Medical University, Beijing, China. More and more
attention has been paid to the important role of hyperlipemia in the
progression of renal injury. In this study the coefficient of hyperlipemia
and loss of functional nephrons were observed. Male SD rats (N = 28)
were divided into four groups. (I) High lipid + uninephrectomized; (2)
High lipid + sham operated for high lipid groups: a 5% cholesterol
supplemented diet were fed 2 weeks after operation; (3) Standard diet +
uninephrectomized; (4) High lipid + uninephrectomized + gemfibrozil,
200 mg/ky body wt/day, a clinically useful antihyperlipemia drug.
Serum lipid was evaluated and the extent of glomerular lesions scored
by computed morphometry as the volume of mesangium/glomerular
(M/G) 12 weeks after this study. Our results showed that dietary lipids
raised serum Chol, LDL, and LDL/Chol. and lowered HDL levels in
both Groups I and 2 more than that in Group 3. But the M/G was
significantly higher in Group 1 (0.157 0.026) than that in group 2
(0.076 0.041), p > Q,oi. Gemfibrozil can significantly reduce the
hyperlipemia, lower Chol, LDL., LDL/Chol., and raise HDL, associ-
ated with alleviation of M/G (0.042 0.010) and proteinuria. Our results
support the role of hyperlipemia in the initiation of glomerular injury
and suggest that efficient reduction of serum lipid level is necessary for
cases of renal disease accompanied by hyperlipemia.
Effects of hyperchotesterolemia on kidneys of rats. J.L. Chen, L.1.
Liao and S.T. Wang, Jiulisong Hospital, Hangzhou, and Zhongshan
Hospital, Shanghai Medical University, Shanghai, China. To clarify
the effects of hyperlipidemia on kidneys of rats, 44 healthy Wistar rats
were randomized to be fed either normal rodent chow supplemented
with 3% cholesterol, 0.5% cholic acid and 10% pig tallow to induce
hypercholesterolemia (E, N = 24), or normal rodent chow as controls(C, N = 19). Serial morphological and biochemical evaluations were
made at 0, 15, 30, 60, and 110 days after initiation of the experiment.
Results showed that: Compared with C, E had higher serum choles-
terol, increased mesangial matrix and mesangial cells, collapsed gb-
merular capillaries, more monocytes in glomeruli, lipid droplets in
glomeruli, tubule lumens and tubule epithelial cells and higher serum
creatinine. Focal fused foot processes were observed in E by electronic
microscopy. Imaged analysis confirmed that the size of glomeruli in E
was larger than that in C. Serum cholesterol had a positive correlation
(P < 0.05) with glomerular area, the number of cell nuclei in glomeruli
and serum creatinine, It is concluded that hypercholesterolemia plays a
role in the pathogenesis of nephropathy in this model, and the degree of
nephropathy is positively correlated with serum cholesterol.
Effects of cyclosporin A and total lymphoid irradiation in experimental
membranous nephropathy in rats. X.P. Huang and S.M. Li, Kidney
Research Institute, Sun Yat-Sen University of Medical Sciences,
Guangzhou, China. In order to study the effects of cellular immunity on
glomerulonephritis, cyclosporin A (CsA) and total lymphoid irradiation
(TLI) were used in Wistar rats to interfere with membranous nephrop-
athy induced by cationic bovine serum albumin (C-BSA) 2.5 mg i.v.
three times a week. Twenty-seven male rats were randomly divided into
3 groups: the control group (N = 11) only received C-BSA; CsA group(N = 8), C-BSA + CsA 5 mg i.p. qd for 4 weeks; the TLI group (N =
8), C-BSA + TLI, received irradiation of gamma rays 150 rads twice
during 7 days before C-BSA injection, total dose was 300 rads. Results
showed that administration of CsA markedly reduced proteinuria in the
CsA group. In the TLI group, proteinuria was lower than that of the
control when lymphocytes in peripheral blood decreased during the 2nd
to 3rd week, but increment of protein excretion was found while the
count of circulating lymphocyte recovered and rose at the end of the 4th
week; that showed a strong relation between proteinuria and the count
of lymphocyte in the peripheral blood (r = 0.87, P < 0.01). The activity
of interleukin 2 was diminished by CsA and TLI (P < 0.05). The
deposition of C3 and IgG showed no significant difference by light
microscopy among the 3 groups except for lessened gbomerular enlarge-
ment in the CsA group. By electron microscopy, CsA treated rats
showed that subepithelial deposits tended to be resolved and absorbed
and with less foot process fusion. In the TLI group, small spikes and
segmental thickened GBM and foot process fusion could be found.
These data suggested that cellular immunity may play an important role
in membranous lesion.
Effect of Captopril on the development of adriamycin-induced glomer-
uloscierosis in uninephrectomized rats. H.S. Wu, J.H. Zhou, Y.O. Wang
et al, Section of Nephrology, Department of Pediatrics, Tongji Medical
University, Wuhan, China. Glomerubosclerosis (GS) was induced by a
single dose (3 mg/kg) of injection of Adriamycin (ADR) in uninephrec-
tomized rats; simultaneously, the effect of Captopril (CAP 10 mg/kg/d)
on the development of GS was observed over a period of 8 months. The
results showed: 3 months after the ADR injection, OS appeared in the
untreated control group and it developed in all the rats in this group
after 5 months. The sclerosis index (SI) was up to 49.9% after 8 months.
But OS in the CAP treated group began to develop as late as 8 months
after ADR injection and their SI was only 2.6%, much lower than that
of the control group (P < 0.01). The mean value of proteinuria and urine
NAG at different stages was also lower in the CAP treated group than
those in the control group. The levels of Cr and Ce,. of the CAP treated
group remained in a normal range, whereas in the control group, Cr was
markedly higher and C. much lower than normal. From the above
results, we considered that CAP may effectively prevent the develop-
ment of GS in ADR injected rats owing to its effect in diminishing the
high perfusion of glomeruli and reducing proteinuria.
The role of complement in IgA nephropathy. W.Z. Zhou and Y.
Zhang, Department of Pathology, Being Medical University, Being,
China. IgA nephropathy was first reported by Berger in 1968. Since
then, many animal models have been made. But they are mainly
subclinical types, lacking complement deposits in mesangium and
showing no hematuria and proteinuria. In order to make animal models
of IgA nephropathy close to human IgA nephropathy and observe the
effects of complement on IgA nephropathy, lipopolysaccharide (LPS)
was added to the mice with cirrhosis IgA nephropathy to activate
complement system and increase the local inflammatory reactions.
Thirty-eight BALB/c mice (females, average weight 14—16 g) were
divided into five groups. Group 1 (N = 9), each was injected (i.p.) with
5% CCl, 0.3 ml (0.024 mg) once a week for nine weeks. On the 4th and
8th week, each was injected (i.v.) with 0.04 mg LPS. Group 4 (N = 10),
each was injected (i.p.) with 0.3 ml olive oil once a week for nine weeks.
Group 5 (N = 6), each was injected (i.p.) with 0.3 ml 0.9% NaCl once
a week for nine weeks. All of the mice were killed on the tenth week.
The serum proteins were analyzed on electrophoresis. The liver and
kidney were examined under LM (light microscopy) (HE, PAS, Mas-
son's, PASM staining) and EM (electron microscopy). Globulin and
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complement in the kidney were examined by direct immunofluores-
cence. The width of mesangium and the number of mesangial cells were
observed by image pattern analysis. The urine samples were collected
on the 9th week from the mice in each group to check protein and red
cells in the urine. The results are that in group 1 and 2, the mice had
cirrhosis and increase of r-globulin IgA and IgG deposited in mesan-
gium; mesangial cells proliferated and mesangium became extensive.
There was a reduction of B1-globulin in serum, C3 deposit in mesan-
gium, and hematuria and proteinuria were found only in group 1.
Groups 3, 4 and 5 were normal on the whole. In summary, LPS led to
activation of complement by alternative pathways, so the lesions of
anthropoid IgA nephropathy occurred in group I. The activation of
complement system is an important factor for glomerular injury in IgA
nephropathy.
Membrane attack complex and glomerulonephritis. Q. Ren, X.J.
Zhou, Z.Q. Wang, et a!, Department of Nephrology, The First Affili-
ated Hospital, China Medical University, Sheyang, China. Using
immunofluorescence, we observed the distribution of the membrane
attack complex (C5b-9, MAC) and IgG, IgA 1gM, C3 FRA in glomer-
ulus of normal subjects and in 40 patients with various types of
glomerulonephritis. Immunofluorescence staining showed that there
was less MAC in normal mesangial matrix, but the MAC deposits in
various glomerulonephritis was widely distributed in the mesangial
matrix, glomerular basement membrane (GBM), tubular basement
membrane (TBM) and Bowman's capsule, increasing with the changes
of renal pathology. The deposition of the MAC was usually associated
with other immune deposits (IgG, IgA, 1gM, C3, FRA). We also noticed
that the proteinuria is not only correlative with the negative charge on
GBM, but also with the amount of MAC deposited in the glomerulus.
These data suggest that MAC is directly related with glomerular injury.
IL-i and TGF/3 mRNA expression in the course of mesangial prolifer-
ative glomerulonephritis (GN). Z.H. Zhao, H. Y. Wang, Y.K. Zhang, et
al, Nephrology Center, Beijing Medical University, Being, China. The
accumulation of extracellular matrix is a prominent feature of progres-
sive glomerulonephritis and glomerulosclerosis. We evaluated the co-
effecting role of interleukin I (IL-l), transforming growth factor f3
(TGF/3), accumulation of collagen IV, (C0IV), laminin, (LN), and
fibronectin, (FN) in the progress of GN. Rat mesangial proliferation and
sclerosis was induced by injection of anti-thymocyte serum (ATS). The
total RNA of glomeruli was extracted from rat kidney at 3, 7, 14, 28, 60
days after ATS administration for Northern blots. Our results suggested
that cytokine IL-i, TGF13 and accumulation of extracellular matrix may
play an important role in the progression of GN.
Study of the role for antioxidants in adriamycin-induced nephrotic
syndrome in rats. H. Gan, P.D. Yin, and S.G. Zhang, Kidney Research
Institute, Sun Yat-Sen University of Medical Sciences, Guangzhou,
China. We studied the antioxidation of superoxide disumutase (SOD),
trans-ferulic acid (T-FA) and ganoderma lucidum (GL) on the rat
models of nephrotic syndrome induced by adriamycin (ADR). ADR
induces a nephrotic syndrome characterized by massive proteinuria,
hypoalbuminemia, hypercholesteremia and ascites. The full expression
of the syndrome developed at 14 days after a single intravenous
injection of ADR. The serum and renal cortices malondialdehyde
(MDA) levels (6.68 0.42 nmol/ml, 10.07 1.29 nmol/mg protein,
respectively) were significantly higher than those in sera and renal
cortices of the normal control group (3.21 0.26 nmol/ml, 3.47 0.37
nmol/mg protein, respectively; P < 0.01). Minimal alterations at light
microscopy, negative IgG, IgA and C3 at immunofluorescence micros-
copy, and only extensive "fusion" of foot processes at electron
microscopy can be observed. These changes appeared similar to those
reported in the literature. Treatment with immunosuppressant cyclos-
porin A (CSA) was ineffective. In contrast, treatment with the antiox-
idants SOD, T-FA and GL were effective. The results suggest that the
associated glomerular lesion is mediated by oxygen free radicals and
lipid peroxidation. The SOD, T-FA and GL treatment groups resulted
in amelioration of proteinuna and serum biochemical index. There were
less severe glomerular morphologic changes in the SOD, T-FA and GL
groups vs. the ADR model. In particular, the serum MDA (3.24 0.25.
3.51 0.41, 3.12 0.23 nmol/ml, respectively) and renal cortices MDA
levels (4.33 0.52, 4.44 0.35, 4.71 1.41 nmol/mg protein,
respectively) in these groups were significantly lower than in the ADR
model group (P < 0.01). These studies suggest that the therapeutic
effects of SOD, T-FA and GL may contribute to their ability to
scavenge free radicals and inhibit lipid peroxidation. Although many
renal diseases are associated with reaction of oxygen free radical and
lipid peroxidation, whether it is possible to use SOD, T-FA and GL as
clinical therapy for renal diseases still needs further research.
Experimental study of immune complex nephropathy caused by Para-
gonimiasis Westermani. M.D. Liu, S.S. Liu, and J.C. Zhu, Department
of Pathology, Wenzhou Medical College, and Yongjia Hospital, Zhe-
jiang, China. Serum antibody level, deposit of immunoglobulin and
complement of the kidney from the dogs infected with Paragonimus
Westermani at different stages are observed with light and electron
microscope in this paper. The results are as follows: (1) Serum of dogs
was detected with direct fluorescent antibody at the frozen section of
the adult worm; results showed that the serum reaction of the dogs
infected with metacercaria was positive but that of the normal control
was negative. (2) Direct immunofluorescent method at the frozen
section of the kidney showed that IgG and C3 could be detected at the
glomerulus at day 50 after infection, 1gM could be detected at day 80,
and immunoglobulin and complement reaction reached their highest at
day 120. In repeat infected group, the deposit of IgG and 1gM was
obvious, but deposit of complement decreased. Under the fluorescence
microscopy immunoglobulin and complement deposit at the glomeru-
lus, normal control showed no reaction. At the frozen section of the
kidney from the infected dogs Paragonimus antigen could be identified
by indirect immunofluorescent method. (3) Microscopically, in day 50
after infection, glomerulus showed atrophy, epithelium of glomerulus
and glomerular tubule showed swelling and Bowman's capsule ex-
panded. In day 80 to 120 after infection glomerulus organization and
fibrosis occurred. (4) Under electron microscope, in day 50 after
infection, the basal membrane of glomerulus thickened slightly. In day
120 after infection, the basal membrane thickened obviously, and
electron-dense granule was found at basal membrane.
The influence of endotoxin on the metabolic of ceftizoxime in mice.
X.H. Tang and G.Z. Xu, Department of Internal Medicine, West China
University of Medical Sciences, Chengdu, China. The ceftizoxime was
studied in the serum and renal cortex after intrapentoneal injection
(i.p.) in normal and endotoxinemic mice. Twenty-four female adult
Wistar mice (weight 150—200 g) were divided into two groups. The first
group was given ceftizoxime 500 mg/kg i.p. and the second group was
given ceftizoxime 500 mg/kg i.p. immediately after endotoxin (E.Coli.
LPS 055:B5) 0.5 mg/kg i.p. At 0.5, 1, 2, and 3 hours after ceftizoxime,
blood and renal cortex tissue homogenates were collected. Concentra-
tion of ceftizoxime was estimated by the method of high-performance
liquid chromatographic (HPLC). The results were: In the first group,
the concentration of serum ceftizoxime and renal cortex ceftizoxime
reached a peak of 547.78 191.47 tg/ml and 525.18 sgIg at 0.5 hour. In
the second group, the peak of serum ceftizoxime concentration was
832.3 421.09 g/ml after ceftizoxime i.p. at 0.5 hour, and that of renal
cortex ceftizoxime 415.94 sg/g at 1 hour. The ratio of renal cortex/
serum ceftizoxime concentration increased with time in both groups,
being larger than 1 after the peak of renal cortical ceftizoxime concen-
tration, though it was not statistically significant. The area under the
curve (AUC) of serum and renal cortical ceftizoxime concentration and
serum ceftizoxime concentration at 0.5, 1, 2, and 3 hours was signifi-
cantly higher in the second group than the first one. Except for 0.5 hour,
the renal cortical ceftizoxime concentration was higher than the first
group, and the ratio of the renal cortex/serum ceftizoxime concentra-
tion was lower in the second group than the first group. In both groups,
the serum ceftizoxime concentration was positively related with renal
cortical cerftizoxime concentration (r = 0.931, P < 0.001 in the first
group and r = 0.80, P < 0.002 in the second group). The t l/2B of serum
ceftizoxime concentration was 0.9 hour in the first group and 1.25 hour
in the second group. Our results suggest that endotoxinemia may affect
the excretion of ceftizoxime through decreasing the glomerular filtrate
rate and secretion function of the renal tubule.
The relationship between sodium retention and the changes of glomer-
ular capillary surface area and Kf in nephrotic syndrome. Y.X. Lu, J.P.
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Chai, Y.H. Lui, et a!, Department of Pediatrics and Laboratory, First
Hospital, Beijing Medical University and Radioisotope Laboratory of
401 Institute, Beijing, China. An animal model of nephrotic syndrome
was produced by intravenous injection of adriamycin 5 mg/kg to 24
Wistar male rats. The rats were paired according to their weight and
divided into experimental and control groups. Eight pairs were ob-
served for 2 weeks and 4 pairs observed for 4 weeks. In the experimen-
tal (E) group, the proteinuria reached the peak level on the 10th day
after injection. At the same time, they showed hypoalbuminemia,
hypercholesterolemia, decrease of serum sodium concentration and
urinary sodium excretion. Compared with the control (C) group, all
showed significant differences (P < 0.05). Under electron microscopy,
foot process fusion of epithelial cells was observed in the E groups,
especially in those observed for 4 weeks. After injection of a silicone
rubber containing chromium into the renal artery, glomerular capillary
diameters were measured. They were more obviously reduced in the F
groups which were observed either for 2 or 4 weeks, than in those of the
C groups (P< 0.005 and P < 0.01, respectively). Then 50 glomeruli
microdissected from each animal were exposed to flux of 2 x iO
neutrons cm2 sec' for 2 hours. After that, the glomerular surface area
was calculated, which was markedly smaller in the E group observed
for 4 weeks than that in the C group (P < 0.05). Since Kf = KXS, it may
be suggested that KS in the E group also declined.
Relationship between plasma ANP and blood volume, glomeruiar ANP
receptors and renin angiotensin system in membranous nephropathy in
rabbits. G. Sn, X.H. Du, H. Jin, and S.L. Wang, China-Japan
Friendship Hospital, Beijing, China. Membranous nephropathy (MN)
was induced by daily i.v. of C-BSA in 10 rabbits, with another 10 as
control. After 2, 4, and 6 weeks of the injection, the pathological
changes of MN were confirmed by LM and EM. Meanwhile, (A-
norprogesterone, standardized casualty rate) plasma renin activity,
(PRA), plasma angiotensin II (PAIl), urine volume, urine protein (Upr)
and urine sodium (UN8) were measured at each interval. After 6 weeks
of injection, blood volume (BY), blood pressure (BP) and glomerular
ANP receptors were also measured. Compared with normal rabbits, we
found a significant increase of ANP (P < 0.05), and a marked decrease
of UN8 (P < 0.01) after 2 weeks of injection. Uv was not significantly
reduced and Upr was positive. Scr progressively rose after 4 weeks and
had a significant increase (P < 0.05) after 6 weeks. PRA and PAIl
markedly decreased (P < 0.01) after 2 weeks. PRA gradually increased
and there was no significant difference compared with normal controls
aged 6 weeks. After 6 weeks of injection, BV and BP were both
significantly elevated (P < 0.05) and numbers of ANP receptors
reduced significantly in the glomeruli. These results demonstrate that in
MN in rabbits, due to water and salt loading, both BY and BP
increased. This is the main factor of elevation of the levels of ANP.
With the deterioration of renal function, however, due to the decrease
of the numbers of glomerular ANP receptors, plasma ANP could not
combine effectively with its receptors to play its physiologic role,
leading to the decrease of GFR, inhibition of diuresis and natriuresis,
and elevation of BP. This may also play a role in the maintenance of
high ANP levels in MN in rabbits.
High salt intake enhances the vasoconstrictive effect of endothelin (ET)
in renal mass reduced rats. C.M. Hao, S. Y. Lin, and B.C. Liu, Research
Lab of Nephrology, Huashan Hospital, Shanghai Medical University,
Shanghai, China. To investigate the role of El in the pathogenesis of
volume dependent hypertension, the following experiments were con-
ducted. (1) The SD rats were subjected to subtotal nephrectomy (516
NX) or sham operation 3 weeks before the experiment, and provided
with high salt diet (0.9% NaCI as drinking water) or normal diet. During
the experiment, an intravenous El infusion (50 ng/min/kg, for 45 mm)
was given, and mean arterial pressure (MAP) was monitored. (2) The
caudal arteries were isolated from the rats that underwent 5/6 NX with
3 weeks of high salt intake (N = 8) or normal salt intake (N = 6). The
cumulative concentration response curve of FT (5 nmol/liter—63 nmoll
liter) and norepinephrine (NE, 10 nmol/liter—10 mmol/liter) was ob-
served. Results: (1) The MAP was higher in 5/6 NX rats with high salt
intake (143 5 mm Hg; N = 6) than those of the 5/6 NX rats with
normal salt intake (125 2 mm Hg N = 6), the intact kidney rats with
high salt intake (119 4mm Hg N = 6) and with normal salt intake (116
9 mm Hg N = 5). After El infusion, the MAP increased in all
animals, but in 5/6 NX rats with high salt intake, the MAP increased to
a greater extent than that of the rats with normal salt intake (maximal
MAP 47.6 4.4 vs. 28.9 8.4 mm Hg, P < 0.01). High salt intake had
no influence on the pressor response to El infusion in the intact rat
kidney. (2) In vitro study, increased sensitivity of the arteries to El has
been observed in 5/6 NX rats with high salt intake compared with that
of the rats with normal salt intake, with EC50 being 18.5 4.4 nmol and
39.9 9.7 nmol (P < 0.05). There were no significant differences in
artery contract response to NE between the two groups. We concluded
that subtotal nephrectomy and high salt intake increased contract
response of the artery to El, which may be related to the pathogenesis
of hypertension in these animals.
Plasma endothelin level and changes in blood volume. Y.H. Wang, S. Y.
Lin, Y. Liu, et al, Renal Research Laboratory, Huashan Hospital,
Shanghai Medical University, Shanghai, China. Endothelin is a very
potent vasoconstrictor which might influence tissue perfusion. In order
to examine if its level varies with changes in blood volume, we studied
plasma endothelin level (pET) after acute different extents of (1) blood
letting, (2) blood transfusion, and (3) isovolemic anemia (that is,
withdrawing an amount of blood then infusing the same amount of
plasma without blood cells). Samples were collected 30 minutes after
each manipulation. It was found that 1% body weight (bw) bloodletting
resulted in a significant decrease in pET compared with that of the
control period (16 9 vs. 20 7 pg/mI P < 0.05). However, pET rose
(23 4 pg/mi) while additional 1% bw blood was lost. Acute blood
transfusion of 1% bw caused a significant rise in pET (43 7 pg/mI)
which was statistically different from that of the control (19 4 pg/mI
P < 0.05). This increment was reversed when the amount of transfusion
reached 2% bw (21 4 pg/mI). Isovolemic anemia, either 1% or 2% bw,
produced no change in pET level compared with that of their controls
(20 11; 20 9; vs. 23 I pg/mi, respectively). PRA level rose
significantly in different volume depletion period (19 11; 23 13 vs.
4 2 ng/ml hr; P < 0.05). But it did not change in either acute volume
expansion or isovolemic anemia of varied degrees. There was a
significant decrease in hematocrit in bloodletting of 2% bw (36 2%) as
well as isovolemic anemia of 1% or 2% bw (36 2%; 30 3%)
compared with that of the control (44 2%, 45 2%). The results
indicate that acute volume depletion causes a decrease in pET level,
which might facilitate tissue perfusion, while the increase in pET after
acute volume expansion might prevent the tissues from overperfusion.
The further changes in pET level, when blood volume changes to more
severe extents, might be caused by other factors which may be altered
by manipulations mentioned above. It seems that dilution caused by
tissue fluid shift after the manipulation does not play an important role
in these changes since isovolemic anemia produces no change in pET
level. We can conclude that the status of blood volume influences pET
level.
Renal nerves and blood pressure elevation after acute saline infusion in
renal mass-reduced rats. C.M. Hao, S. Y. Lin, Y.H. Wang, et al,
Research Lab of Nephrology, Huashan Hospital, Shanghai Medical
University, Shanghai, China. The purpose of this study was to inves-
tigate the role of renal nerves in the pathogenesis of volume dependent
hypertension in renal mass-reduced animals. The experiment was
performed on anesthetized SD rats. The results are as follows: (1) 5%
BW saline infusion raised mean arterial pressure (MAP) greatly in
unilateral nephrectomized rats (from 89 6 mm Hg to 124 3 mm Hg,
N = 6) more than that in intact kidney rats (88 5 to 106 3 mm Hg,N = 8). (2) In the unilateral nephrectomized rats, denervation of the
remnant kidney (N = 6) ameliorated this MAP elevation (at the end of
the loading, the MAP was 109.5 4.4 mm Hg and 123.8 3.2 mm Hg,
respectively, P < 0.05). Selective cutting of the afferent fibers of the
remnant kidney (ipsilateral rhizotomy l8-L2, N = 6)produced a similar
result. (3) In one kidney ligated rats, saline loading at first decreased
renal sympathetic nerve activity (RSNA, —19.3 6.4%, N 8), then
increased it after the loading was stopped (+ 14.9 5.8%). Denervation
of the remnant kidney (N = 8) enhanced the suppression (—40.1
5.6%) and the RSNA remained decreased after the loading was stopped.
When the one kidney ligated rats were sino-aortic denervated and
vagatomized (N = 5), saline loading produced a gradia (increase in
RSNA which reached 147.4 8.1% 40 minutes after the loading).
Denervation of the remnant kidney (N = 5) discontinued this increase
in renal nerve activity. (4) Acute saline loading produced an inhibition
of the afferent renal nerve activity of the remnant kidney, which
reached its lowest level at the 40th minute after the loading (56.3 5.2%
of that before loading, N = 5). It is suggested that the afferent renal
nerve may be involved in the blood pressure elevation in renal mass-
reduced rats after acute saline loading. The possible mechanism may be
that saline loading can inhibit the afferent renal nerve activity, leading
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to a decreased inhibitory effect of the afferent renal nerve on the
sympathetic nervous system, which causes a blood pressure elevation.
Effects of endothelin on glomerular mesangial cells. L.J. Ma, Y.P.
Chen, J. Gao, and H. Y. Wang, Nephrology Center, BeingMedical
University, Beijing, China. The newly discovered endothelium-derived
peptide, endothelin (ET), has potent contractile and mitogenic effects
on vascular smooth muscle cells (VSMC). Glomerular mesangial cells
(MC) share similarities in many ways with VSMC, so we designed this
study to examine the inflammatory responses of the cultured rat MC to
ET-1. Firstly, the contractile action of MC to ET-l was examined by
phase contrast microscopy. MC showed a marked contraction when
they were incubated with ET-l (l09M, 108M and l07M) for 30
minutes. Secondly, the proliferation of MC after stimulation of ET-l
was evaluated with 3H-thymidine incorporation. ET-l, incubated with
MC for 24 hours, led to MC proliferation in a dose-dependent manner
with a threshold at 109M. ET-l also time-dependently resulted in MC
proliferation when the FT-I at 107M was incubated with MC more
than 18 hours. Thirdly, the activity of tumor necrosis factor (TNF)
released by MC in response to ET-l was measured with 1929 cell lytic
assay. The activity of TNF was at a lower level without ET-1 stimula-
tion, but significantly increased after incubation with ET-i in a dose-
dependent way (l0°M, 109M and 108M). ET-l can stimulate MC
contraction, proliferation and release of TN F-like factor in vitro, which
may contribute to the development of glomerulonephritis in vivo.
Analysis of surface antigens of mesangial cells in mice by flow cytom-
etry. X.M. Chen, L.F. Yu, and Q.L. Cheng, Department of Nephrol-
ogy, The Great Wall Hospital, Beijing, China. Twenty-one kinds of
monoclone antibody were labeled with FITC, PE, APC and Bi-TR,
respectively, and used to determine the surface antigen marker of
giomerular mesangial cells in BALB/c mice by flow cytometry. The
results showed that 24.4% mesangial cells in the mice expressed Mac-i
marker, 19.4% Ly 5.2 marker, and 12.9% fibronectin, laminin and
collagen IV surface antigen marker. Only 5% mesangial cells did not
express any surface antigens. The ingredients of fibronectin, laminin
and Collagen IV were presented in the cytoplasm of all the mesangial
cells. We also found that the surface antigens of mesangial cells were
significantly different according to their different species.
The possible role of IL-i autocrine and paracrine in mesangial cells
(MSc). Z.H. Zhao and H. Y. Wang, Nephrology Center, Beijing Medi-
cal University, Beijing, China. It was reported that autocrine and
paracrine of cytokines play a central role in the pathogenesis of
glomerulonephritis (GN) and glomerulosclerosis (GS). Previous studies
demonstrated that IL-I like factor is not only produced by MSc, but
also stimulates MSc proliferation. To examine antocrine and paracrine
of IL-i in MSc in molecular biological level, we studied the effects of
rIL-1 on MSc IL-i and TGFB mRNA gene expression. Total RNA was
extracted from subcuitured MSc in the presence or absence of rIL- 1 in
3, 6, and 12 hours and dot blots. The MSc proliferation was dose-
dependent on rIL-l, and LL-l promoted MSc IL-i and TGFB mRNA
gene expression. Our results support the possible role of IL-I autocrine
and paracine in MSc.
The effect of interleukin-1 on mesangial cells (mSc) TGFI3 mRNA
expression and matrix synthesis. Z.H. Zhao, H. Y. Wang, S.L. Zhu, et
al, Nephrology Center, Beijing Medical University, Beijing, China.
Transforming growth factor f3 (TGFI3) is a potent modulator of cell
growth and extracellular matrix metabolism in most types of cultured
cells. Whether cultured MSc may also produce TGFf3 is still unknown.
The effect of IL-I on glomerulosclerosis (GS) has become an interesting
topic in the mechanism study of glomerular diseases. In this study, the
effects of IL-i on MSc TGF/3 mRNA gene expression and matrix
synthesis were investigated. Total RNA was extracted from MSc and
dot blots, 35S in corporation and collagen synthesis of subcultured MSc
were measured by addition of rIL- 1. The results showed that subcul-
tured MSc could have the expression of TGF/3. rIL-l/3 could stimulate
MSC TGFI3 mRNA gene expression in 3, 6, and 12 hours and promote
35S incorporation (1586 282 vs. 700 109, P < 0.01), and collagen
synthesis (6.81 0.70 vs. 4.20 0.68, P < 0.01) in subcultured MSc.
The results support the conclusion that IL-I plays an important role in
the development of GS.
Interleukin 6 production and its mRNA gene expression in mice
glomerular mesangial cells. X.M. Chen, Q.L. Cheng, L.F. Yu, et al.
Department of Nephrology, The Great Wall Hospital, Being, China.
The relationship between Interleukin 6 (IL-6) and glomerular mesangial
cells (MC) was investigated by the IL-6 production and its mRNA gene
expression in the MC of mice. The MC of BALB/c mouse was cultured
and then verified by anti-keratin and anti-desmin antibodies. The
cultured MC were divided into two parts, one with Mac-i marker and
another without Mac-l, by flow cytometry. The IL-6 activity of
cultured supernatants of MC was measured using the IL-6-dependent
cell line subclone (MH6O). The results showed that the mouse MC could
produce IL-6 and the level of IL-6 produced by MC with marker of
Mac-I was higher than that without Mac-I. The RNA extracted from
the cultured mice glomerular mesangial cells was hybridized in dot blots
with 12PdCTP labeled IL-6cDNA probe and the dot blot autoradio-
graph showed a positive expression of IL-6mRNA gene in mice
mesangial cells.
The effect of dexamethasone (Dex), caltitonin generelated peptide
(CGRP) and Tamm-Horsfall glycoprotein (THP) on the interaction of
mesangial cells (MSC) and interleukin 1 (IL-i). Z.H. Zhao and H. Y.
Wang, Nephrology Center, Beijing Medical University, Beijing, China.
It has been reported that IL-I plays a major role in the immunological
and inflammatory reactions. The influence of Dex, CGRP, and THP on
the suppression of IL- 1 production and its increasing effects on MSc
proliferation was studied by a thymocyte comitogenic bioassay, dot
blots and MSc 3H-thymidine incorporation. Our results indicated that
CGRP inhibited MSc IL-I mRNA expression, whereas THP antago-
nized the promoting effect of IL-i on MSc proliferation, but had no
inhibiting effect on MSc IL-l mRNA expression. Dex not only de-
creased the production of IL-i by inhibiting MSc IL-I gene expression,
but also antagonized the promoting effect of IL-i on MSc proliferation.
It is suggested that these drugs antagonize IL-i in MSc level which may
stop the pathogenesis circle of MSc and IL-I.
The effects of LPS, HrIL-2 and protamine on the proliferation of rat
glomerular epithelial cells (GECs) and incorporation of 35S04 into cell
layers in vitro. P.L. Wang, B.K. Zhang, Y.P. Chen, J. Y. Yang, andJ.X.
Zhang, First Hospital, Beijing Medical University, Beijing, P.R. China.
The sulfated macromolecules synthesized by the cultured rat GECs are
heparan sulfate proteoglycan (HSPG), which plays an important role in
maintaining the glomerular charge-selective function. We have investi-
gated the effects of lipopolysaccharide (LPS, 6.25 ng/ml), human
recombinant interleukin-2 (Hr1L-2, 2.5 U/mI), and protamine sulfate
(PtS, 100 /zglml) on the proliferation of rat GECs and incorporation of
35SO4 into cell layers in vitro. A method of 3H-TdR and 35S-Na2SO4
dual isotope labeling technique was used. Statistical analysis was done
using analysis of variance for both 3H-TdR uptake and 35S04 incorpo-
ration, and analysis of covariance only for the latter. The results are
shown in the following table.
3HTdRa p
Control 3655 1476
LPS 1367 440 <0.01
Control 3640 1460
HrIL-2 2162 940 <0.05
Control 3655 1476
PtS 2075 630 <0.05
35s04a
-—
P 35SO4I p
4390 2479 3419
1966 811 <0.05 1955 >0.05
4390 2479 2969
1819 446 <0.05 1802 <0.05
4390 2479 4150
2325 850 <0.05 2839 >0,05
a Mean SD, DPM; b Adjusted mean, DPM.
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These results show that LPS, HrIL-2 and PtS inhibited the proliferation
of rat GECs. HrIL-2 also directly inhibited the incorporation of 35S04
into cell layers, but the roles of LPS and Pts, which decreased
35S04-content, only came from their inhibition effects on cell prolifer-
ation. We propose that the decreased production of HSPG by GECs
may contribute to the development of proteinuria.
Inhibition of TNF and IL-i production of macrophages by rheum
officinale. W.X. Hu and L.S. Li, Jinling Hospital, Nanjing, China.
Rheum Officinale (RO), a traditional Chinese medicine, has been shown
to retard effectively the progression of chronic renal failure (CRF). We
also proved that RO could retard the increment of BUN and SCr
CRF, diminish the hypermetabolism and hypertrophy in remnant kid-
ney and suppress the proliferation of mesangial cells. In this study, the
effect of RO on the production of TNF and IL-i by macrophages (Mo)
was investigated, which has been confirmed to play an important role in
the development and progression of glomerulonephritis. Mo were
obtained from the abdominal cavity of SD rats, and three RO prepara-
tions were applied: Emodin, Polysaccharide of RO (ROP) and sera
obtained from rats fed with alcoholic extracts of RO (RO sera). The
results showed that TNF activity was much lower in the supernatant of
Mo treated with Emodin or RO sera than in the LPS-stimulated
controls. Emodin also showed dose-dependent inhibition of IL-I pro-
duction, while ROP (25 and 50 g/m1) had no effects on either TNF or
IL-i production by Mo. It is concluded that the inhibitory effect of RO
on the production of certain inflammatory mediators may be another
important mechanism of RO in the treatment of CRF.
A study of cell transfer in experimental crescentic nephritis. X. I'. Ding,
Department of pathology, Xuzhou Medical College, Suzhou, Jiangsu,
China. We investigated the role of mononuclear in the formation of the
crescentic glomerular nephritis. The marrow monocytes from New
Zealand white rabbits were cultivated in Teflon bags. The rabbits were
given preimmunization, then they were given nephrotoxic serum (NTS)
intravenously 0.8 mllkg body weight. One week later, each rabbit was
treated with a total dose of 800 rad 60CO-r-ray irradiation on its whole
body. Two days later, all rabbits were divided into two groups. In group
1, 108 cultured cells were injected intravenously into each animal with
some buffer solution; in group II, only 10 ml of the buffer solution was
injected intravenously. The results show that there was no significant
difference in renal function and proteinuria between the two groups
before they received irradiation. The renal function changed and
proteinuria was significantly higher in group I than in group II on days
17 and 30 after NTS (P < 0.001). The linear deposition of IgG and C3
along the glomerular basement membrane was found in both groups. On
day 7, after the animals, in group I received the cultivated cells, the size
of the glomeruli became larger, and an accumulation of cells in
Bowman's space forming crescents was observed (83.95 9.51%). The
wall of the Bowman's capsule was broken. There were many ANAE
(a-naphthyl-acetate esterase) positive cells (73.48 18.72%) and la-
beled 3H-TDR cells (10.3 6.8%) in the cellular crescents. In group II,
slight morphologic changes could be seen in the glomeruli. No cellular
crescents were found. These results suggest that the mononuclears can
induce the formation of cellular crescents and are responsible for the
structure damage and abnormal function of the glomeruli in nephritis.
Further study on renotropin. W.X. Hu and L.S, Li, Jinling Hospital,
Nanjing, China. We found previously that sera from uninephrecto-
mized rats could stimulate the DNA synthesis of renal tubular epithelial
cells and mesangial cells (MC). The maximal stimulation appeared at 48
hours after the operation, and this renotropic activity has organ
specificity but not species specificity. In this experiment, we attempted
to purify partially the renotropin from sera 48 hours after uninephrec-
tomy by anion-exchanger FPLC and HPLC. Renotropic activity was
expressed by 3H-TdR incorporation of tubular cells and MC in vitro and
of mouse kidney in vivo. The active fraction (renotropin) was obtained
by FOLC and HPLC. The apparent molecular weight was estimated to
be 10 kg by HPLC. Renotropin stimulated DNA synthesis of mouse
kidney in vivo as well as the rat MC in vitro, reaching the maximal
stimulation at 30 jsg/ml. In addition, anti-EGF antibody had no effect on
the renotropic activity. In the present study, we could not obtain a
purified renotropin, but the results presented further evidence to
support the existence of renotropin. Further purification studies have
been under way in our laboratory.
Erytbropoietin, produced by cell culture (cc-huEPO). Y.F. fin, G.Z.
Tang, H. I'. Zhang, et al, Biochemistry Department, Nanjing Univer-
sity, Nanjing, China. A new technique of generating cc-huEPO in vitro
by human kidney cell culture was successfully developed. A prepara-
tion with specific activity of 100,000—120,000 U/mg has been obtained
from cell-conditioned medium by DEAE cellulose, phenylsepharose
and sephacryl chromatography. Purified cc-huEPO is a glycoprotein
with a pH of 4.1 and Mr of 34,000 (as determined by SDS-PAGE) and
a more than 33% carbohydrate content. Results of immunoassay
indicated that the cc-huEPO combined with monoclonal antibody of the
N-terminal sequence peptide of EPO specifically. Anemia in mice
induced by injection of acetyphenyl hydrazin and in rats caused by
partial (5/6) nephrectomy and Heymann nepbritis were significantly
corrected by treatment of cc-huEPO. When cc-huEPO deglycosylated
by trifluoromethanesulfonic acid, it still maintains about 75% activity
which was determined in vitro by CFU-E number of liver cells of 13
days fetal mice, but deglycosylation fully destroyed the biological
activity in the anemia animals mentioned above. Data of toxicology and
pharmacology experiments indicated that the minimum lethal dose in
mice is higher than 750,000 U/kg i.v. and 1,500,000 U/kg i.p. Subacute
toxicity test of rats and chronic toxicity test of rats and dogs showed
that cc-huEPO is low toxic, allergen free and very safe. Data of clinical
studies on cc-huEPO were reported by Jingling Hospital, Nanjing. The
therapeutic efficacy of cc-huEPO in the treatment of 30 anemia patients
with chronic renal failure (receiving hemodialysis) were positive. Pa-
tients received cc-huEPO 150 U/kg i.v. 3 times a week for 5 to 10
months after dialysis. Their Hb and Hct level increased markedly: Hb
from 5.1 0.4 g/dl to Hb 8.1 0.6 g/dl and Hct from 15.8 1.2 vol%
to 24 2.0 vol%. The need for regular blood transfusion has also been
obviated in all patients who were previously transfusion-dependent.
Life quality of the patients has been improved greatly. Marrow phase
exam indicated that the proliferation of erythroid marrow was stimu-
lated and the erythroid system ratio was more than 30% in most
patients. No anaphylaxis happened. Hypertension appeared in 3 pa-
tients but could be easily managed with antihypertension medication.
Vascular thrombotic events have not been observed.
Prostaglandin and interstitial nephropathy. N.P. Yang, G.Z. Xu, and
X.R. Liu, Department of Nephrology, First Hospital, West China
University of Medical Sciences, Chendu, China. Thirty-two adult
female Wistar rats were randomly divided into 4 groups: endotoxin
injection (E); ceftizoxime injection (C); endotoxin plus ceftizoxime
injection (E + C), and control. All rats were killed 1 hour after
abdominal cavity injection. Statistic analysis showed no significant
difference in serum creatinine and BUN among these groups (P > 0.1,
> 0.2). There were little changes in enzyme activity of tubular cell
mitochondria in experimental groups at early stage, but swelling of
tubular cells, reduction of matrix and swollen mitochondria were
prominent. Meanwhile, serum and renoparenchymal TXB2/6-keto-
PGF1a. Ultrastructural changes mentioned above resulted from inter-
stitial ischemia and hypoxia due to the decrease of renal blood flow and
glomerular filtration rate. Seral creatinine and BUN showed no changes
at the early stage, but TXB2/6-keto-PGF1a is sensitive and can be an
indicator for the interstitial nephropathy.
